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1 
Zusammenfassung 
Diese Studie verbessert das Verständnis von Differenzierung und Rekrutierung 
mesenchymaler Stammzellen (MSC) im Kontext der Tumorstromabildung. Dieses 
ist eine wichtige Voraussetzung für die therapeutische Verwendung dieser Zellen, 
zum Beispiel in der Gentherapie. Um die therapeutische Anwendung von MSCs 
spezifischer gegen Tumorgewebe zu richten und dadurch Nebenwirkungen zu 
reduzieren, ist die bessere Erforschung der Rekrutierungs- und 
Migrationseigenschaften der MSCs notwendig. Es gibt Hinweise, dass wichtige 
Aspekte der MSC Biologie dem Wnt Signalweg unterliegen. In vitro wurde der 
Einfluss von Prekonditionierung humaner MSCs auf ihr Migrationsverhalten 
gemessen. Nach 24h und 48h Prekonditionierung von primären MSCs mit 
rekombinanten humanen Wnt3a Protein, welches den kanonischen Wnt Signalweg 
aktiviert, wurden signifikant zielgerichtetere Migrationseigenschaften im Vergleich 
zur unstimulierten Kontrolle gemessen. Nach weiterer Kultivierung der 
prestimulierten MSCs für zwei bis drei Passagen, wurden keine erhöhten Parameter 
für gerichtete Migration mehr gemessen. Daraus lässt sich schließen, dass der 
chemotaktische Effekt der Wnt3a Prestimulierung auf MSCs temporär und 
reversibel ist. 
Der Wnt und Hedgehog (HH) Signalweg sind hochkonservierte Signalkaskaden, die 
in Karcinogenese und Differenzierung eine wichtige Rolle spielen. Liganden dieser 
Signalwege werden autokrin, parakrin und juxtakrin im Tumormilieu sezerniert und 
können diverse Zellen im Tumor aktivieren. Deshalb wurden im zweiten Teil dieser 
Arbeit spezifische synthetische Promotoren für die genannten Signalwege, auf ihre 
mögliche Aktivität im Tumormilieu untersucht – als Mechanismus für die potentiell 
erhöhte Expression von Zielgenen im Tumormilieu. Als erster Schritt wurde die 
jeweilige Promotoraktivität im experimentellen Tumormilieu charakterisiert. Mit Hilfe 
des Sleeping Beauty Transposon Systems wurden stabile Reporterzelllinien 
generiert, die Gaussia Luciferase als Korrelat für Promotoraktivität in den Überstand 
sezernieren. Hek293 Zellen wurden als einfach zu kultivierende und leicht zu 
transfizierende Zellen zur Prüfung der Konzepttauglichkeit verwendet. Hek293 
Zellen die stabil mit Wnt oder HH Reportertransgenen transfiziert wurden, zeigten 
erhöhte Promotoraktivität in Kokultur mit Tumor- und Makrophagenzelllinien; auch 
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Tumorzell- und Makrophagenüberstände konnten die Hek293 Reporterzellen 
aktivieren. Im Gegensatz dazu, konnte in immortalisierten mesenchymalen 
Stammzellen (iMSC), die mit den gleichen Transgenen stabil transfiziert wurden, 
kein erhöhtes Signal gemessen werden – weder in Kokultur, noch mit 
konditionierten Überständen. Exposition der iMSC Reporterzellen mit 
aufkonzentriertem Makrophagenüberstand, zeigte signifikant erniedrigte 
Reporteraktivität. Zusammenfassend kann man sagen, dass Wnt- und HH-
Reportertransgene im Tumormilieu beeinflusst werden, deren Auf- oder 
Abregulierung jedoch von der Reporterzellline abhängig ist. Aus den vorliegenenden 
Daten lässt sich schließen, dass mehr Signalwege getestet werden müssen, um 
einen geeigneten Promotor für die spezifische Expression von (Therapie-)genen in 
stabil transfizierten MSCs im Tumormilieu zu identifizieren. 
Um das Tumormilieu und dessen möglichen Einfluss auf MSC zu erforschen, wurde 
es zum Ziel gesetzt Reporterzellen mit einem fluoreszierenden Protein als 
Korrelation zur Promotoraktivierung zu etablieren. Diese könnten dazu verwendet 
werden in einem 3D Tumormodel, einem sogenannten Tumorspheroid, nicht nur die 
Invasionsfähigkeit, sondern auch die Beeinflussung der Promotoraktivität 
währenddessen, in den verschiedenen Zonen des Tumormodels, zu messen. Stabil 
transfizierte iMSC und primäre MSC mit einem Wnt-Reportertransgen, dessen 
Expression an das fluoreszierendes Protein Tomato gekoppelt war, wurden 
etabliert. Die Funktionalität der Wnt-Reporterzellen wurde durch erhöhte 
Fluoreszenz nach Wnt3a-Stimulation in der FACS Analyse gezeigt. Reporter-iMSC 
wanderten in ein Tumorspheroid ein und die Fluoreszenz konnte mit einem 
Lichtscheibenmikroskop gemessen werden. Es lagen aus anderen Experimenten 
Hinweise vor, dass in iMSC und MSC diese Wnt-Reporterelemente durch 
Tumormilieu nicht stimuliert werden konnten. Daher war die Etablierung dieses 
Assays mit Wnt-Reporter-Plasmiden nicht erfolgreich. Da das fluoreszierende 
Protein Tomato über viele Passagen hinweg exprimiert wurde und Aufgrund seiner 
Leuchtkraft gut in unserem Fluoreszenzmikroskop und FACS detektiert werden 
konnte, bietet sich ein neuer Etablierungsversuch mit diesem Protein und einem 
anderen Reportertransgen an. 
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Summary 
This study improves our understanding of the mechanisms of mesenchymal stem 
cell (MSC) differentiation and recruitment in the context of tumor stroma formation, 
an important prerequisite for the therapeutic utilization of MSCs, for example as 
gene delivery vehicles. In order to reduce side effects, and to make gene delivery 
more targeted to tumors, the behavior of MSCs in response to tumor-derived signals 
was observed under different conditions. Wnt signaling is thought to underlie 
important aspects of MSC biology. The effect of prestimulation of human MSCs with 
the canonical Wnt activator protein Wnt3a on migration towards tumor conditioned 
medium was studied. After 24h and 48h of prestimulation of primary MSCs with 
recombinant human Wnt3a, various parameters indicated enhanced directed 
migration. No memory effect was observed, suggesting that the prestimulated cells 
did not show enhanced chemotactic parameters after culture for two to three 
passages. Therefore, Wnt3a prestimulation exhibits temporary effects on MSCs 
which are fully reversible.  
Canonical Wnt and Hedgehog (HH) signaling are highly conserved pathways 
involved in carcinogenesis and differentiation. The ligands triggering these pathways 
are secreted into tumor environments, and through autocrine, paracrine or juxacrine 
signaling, can activate the diverse cells within tumors. In the second part of this 
thesis, the potential activation of synthetic Wnt and HH promoters in primary MSCs 
were evaluated as a mechanism for the potential induced expression of target 
genes in the tumor milieu. As a first step to characterize the potential promoter 
activity in response to experimental tumor-derived signals, a set of Sleeping Beauty 
transposon-based reporter plasmids were generated for stable integration of 
complex transgenes into target cells that use Gaussia Luciferase secretion into the 
growth media as a read-out for promoter activity. Because Hek293 cells are easy to 
cultivate and transfect, this cell line was used in control experiments. In in vitro 
experiments Hek293 cells were stably transfected with Wnt- or HH-responsive 
transgenes. The resulting lines showed elevated signaling activity in co-culture and 
with supernatant of various tumor cell lines and a macrophage cell line. In contrast, 
an immortalized MSC cell line (iMSC) stably transfected with the respective reporter 
plasmid did not show induction, rather a decreased signal.  
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Exposure of reporter iMSCs to concentrated supernatant from a macrophage cell 
line showed significantly decreased reporter activity. In conclusion, Wnt- and 
Hedgehog-responsive reporters engineered into cell lines can be positively and 
negatively influenced by tumor-relevant signals depending on the reporter line. 
Therefore, more pathways need to be tested to find the most suitable promoter for 
(therapeutic) gene expression in MSCs in the tumor milieu. 
In order to investigate the tumor milieu and its potential effect on MSCs, reporter 
cells with a fluorescent protein read-out were established to measure promoter 
activity of stably transfected MSCs while invading a 3D tumor model, a so-called 
tumor spheroid. Changes in reporter activity would indicate pathway specific 
influences on MSCs exposed to various chemokine and oxygen gradients in the 
tumor spheroid. Primary MSC and iMSC with a Wnt-responsive element linked to 
fluorescent protein expression were established; Fluorescence activated cell 
scanning (FACS) analysis showed increased fluorescence after Wnt3a stimulation. 
Reporter iMSC invaded a tumor spheroid and fluorescence could be detected in a 
light sheet microscope. No evidence of reporter transgene activation in primary 
MSCs or iMSCs in the tumor milieu made the establishment of this assay with those 
pathway specific elements unsuccessful. However, the fluorescent protein Tomato 
was stably expressed over many passages and could be easily detected in our 
fluorescence microscope and FACS because of its brightness. When trying to 
establish this assay with another pathway specific element – known to be activated 
in MSCs in the tumor milieu – Tomato would be a suitable fluorescent protein.  
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Introduction 
Mesenchymal stem cells (MSCs) 
Mesenchymal stem cells (MSCs) are pluripotent cells found in the bone marrow and 
other tissues including; peripheral blood, skeletal muscle, umbilical cord, amniotic 
fluid, liver, adipose tissue and dental pulp (Ullah, Subbarao, & Rho, 2015). No single 
markers exist for the characterization of MSCs, the minimal criteria for defining 
multipotent mesenchymal stem cells as outlined by the International Society for 
Cellular Therapy is defined by their expression of CD105, CD73 and CD90, which 
are associated with stromal cell biology, and the lack of expression of CD45, CD34, 
CD14 or CD11b, CD79α or CD19 and HLA-DR surface molecules which are 
associated with hematopoietic or endothelial cells. MSCs are thus defined as non-
hematopoietic, multipotent stem cells, which are able to differentiate into adipose, 
bone and cartilage tissue and to grow adherently on plastic surfaces (Dominici et al., 
2006). MSCs can show extensive heterogeneity.  
Research on MSCs is a relatively new field; MSCs were first described in 1974 by 
Friedenstein et al. as a population of cells derived from bone marrow that had the 
appearance of fibroblasts and that could differentiate into adipocytes, osteocytes 
and chondrocytes (Friedenstein et al., 1974). In the 1990s these cells were termed 
mesenchymal stem cells.  
MSC homing to damaged tissue 
In their role as mediators of tissue repair, MSC become mobilized from various 
niches and undergo directed migration to damaged tissue (J. F. Ji, He, Dheen, & 
Tay, 2004; Satake, Lou, & Lenke, 2004). Because solid tumors resemble chronically 
damaged tissue with extensive hypoxia, necrosis and inflammation, MSC are 
actively recruited to growing tumors where they can act as progenitors for cells that 
make up the tumor stroma (Studeny et al., 2002). Adoptively applied MSC have 
been shown to undergo recruitment of a variety of experimental tumors including; 
gliomas, melanoma, breast cancer, colon cancer, hepatocellular carinoma and liver 
metastasis of colon cancer, as reviewed by Bayo et al. (Bayo et al., 2014). 
Despite the considerable amount of literature describing the phenomenon of MSC 
migration, the underlying mechanisms of MSC recruitment are not fully understood. 
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It is generally assumed that MSC homing follows the same steps described for 
leukocyte homing, e.g. mediated through integrins, selectins, chemokines and 
adhesion molecules (Figure 1). 
 
 
Figure 1. Mesenchymal stem cell (MSC) recruitment to tumor milieu 
MSCs are recruited to the tumor milieu by various factors, including chemokine 
gradients. Although the homing mechanism is not yet fully understood, it has been 
suggested that certain cytokines and chemokines (VEGF, CCL2, and 
CCL5/RANTES), as well as ANGPT2, released into the peripheral circulation help 
guide cells to tumors. A) recruitment, B) rolling, C) arrest within the vasculature, and 
D) transmigration across endothelium may be mediated by the mechanisms and 
adhesion molecules also direct leukocyte homing and adhesion cascade. 
Abbreviations: ANGPT2, angiopoietin 2; CCL, C-C chemokine ligand; MSC, 
mesenchymal stem cell; VEGF, vascular endothelial growth factor (Keung, Nelson, 
& Conrad, 2013). 
Several important cytokine/receptor pairs for MSC homing and transmigration have 
been identified, these include: SDF-1/CXCR4, SCF-c-Kit, HGF/c-Met, 
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VEGF/VEGFR, PDGF/PDGFr, MCP-1/CCR2, and HMGB1/RAGE as reviewed by 
Momin et al (Momin, Mohyeldin, Zaidi, Vela, & Quinones-Hinojosa, 2010). MSCs 
express CXCR4 and c-met receptors, and can be attracted by stromal-derived factor 
(SDF-1) and hepatocyte growth factor (HGF) gradients in vitro. Moreover, the 
expression of matrix metallo- proteinase-2 (MMP-2) is downregulated in MSCs 
when they contact tumor conditioned medium.  SDF-1 and HGF are upregulated in 
damaged tissue (Son et al., 2006).  
CXCR4 expression can be detected in MSCs, but often not on the surface (Von 
Luttichau et al., 2005), whereas Lourenco et al. suggest that tumor conditioned-
medium can trigger the expression of intracellular stored CXCR4 on the cell surface, 
thus improving the response to a chemotactic gradient, independently of gene 
expression (Lourenco et al., 2015). Macrophage migration inhibitory factor (MIF) 
may also be a key player in MSC migration towards tumor conditioned-medium, 
acting through the CXCR4 receptor (Lourenco et al., 2015). Ponte et al. also 
concluded that an inflammatory milieu enhances MSC migration. In a transwell 
migration assay, MSCs prestimulated with tumor necrosis factor α (TNFα) showed 
enhanced migration compared to unstimulated control, however, interleukin-1β did 
not alter the migratory ability (Ponte et al., 2007). Moreover, TNFα prestimulated 
MSCs also showed increased migration capacity towards the chemokines 
RANTES/CCL5, SDF-1/CXCL12, Macrophage-derived chemokine (MDC) and the 
growth factor angiopoietin-1, as compared to unstimulated MSCs (Ponte et al., 
2007). 
 
Understanding MSC homing and finding ways of enhancing their tropism for solid 
tumors is important for enhancing the therapeutic application of MSCs. There are 
various approaches that have been suggested to modulate the homing efficiency of 
MSCs these include; the use of culture conditions or prestimulation to enhance the 
expression of homing molecules, engineering of novel cell surface receptors to 
improve homing, optimizing the mode of administration of MSCs to an organism and 
the modification of target tissue to better attract MSCs. 
 
Various factors have been evaluated to precondition MSCs in vitro, also called 
MSC priming. Effects on the cells’ behavior, including homing potential, and on 
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surface molecules, indicating differentiation, have been reported (Lu, Haider, Jiang, 
& Ashraf, 2009). Moreover, MSCs precultured under hypoxic conditions prior to 
transplantation were shown to improve their tissue regenerative potential in a 
mouse model, and enhanced their migration rate in vitro (Rosova, Dao, Capoccia, 
Link, & Nolta, 2008). 
 
The signaling network controlling MSC homing is complex and not yet fully 
understood, it may show differences based on target tissues. In vitro models were 
used to observe the migratory behavior of MSCs. Aiming at better understanding 
and improving MSCs tumor homing not only in vitro, but also potentially in vivo, 
varying prestimulation conditions were evaluated. 
 
The aforementioned studies evaluated several important signaling molecules for 
their influence on MSC migration. Wnt and Hedgehog pathways are associated with 
the migratory capacity of cells. Thus, the effects of modulation of these pathways 
could be monitored in part through quantification of migratory capacity. To date, the 
effect of canonical Wnt or Hedgehog pathway activation on the tropism of MSC for 
tumor signals has not been described. 
MSCs within the tumor milieu 
In addition to malignant cells, the tumor milieu is also composed of inflammatory 
cells (neutrophils, macrophages, mast cells and lymphocytes), newly formed blood 
vessels, and a large number of fibroblasts and myofibroblasts which together are 
referred to as the tumor stroma. The tumor stroma effects cancer progression, for 
example, by driving tumor cell proliferation, angiogenesis and metastasis.  
The tumor environment has been described as resembling a wound that does not 
heal (Dvorak, 1986; Schafer & Werner, 2008). MSCs have been shown to act as 
precursor cells for many of the cells that make up the tumor-associated stromal 
component. Within the tumor microenvironment, MSCs have been shown to give 
rise to carcinoma associated fibroblasts (CAF), pericytes, endothelial cells, and 
fibrovascular stroma (Mishra et al., 2008).  
Tumor-resident endothelial cells and stromal cells produce various chemokines and 
growth factors, such as CCL2, CCL5, and angiopoietin 2 (Keung et al., 2013). MSCs 
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can respond to angiogenesis signals by secreting various factors such as leukemia 
inhibitory factor, macrophage colony-stimulating factor, macrophage inflammatory 
protein-2 and vascular endothelial growth factor (VEGF) (Suzuki et al., 2011). MSCs 
are seen as key players in generating and moderating the tumor microenvironment, 
thus, genetically modified MSCs constitute a potential therapeutic vehicle. 
MSCs are thought to be tumor promoting as well as immunoregulatory. They can be 
immune suppressive, for this reason it has been suggested that they could help the 
tumor escaping from immune surveillance (Han et al., 2012). MSCs have been 
described to suppress a variety of immune cells, including dendritic cells, natural 
killer cells, and B- and T- lymphcytes (Glennie, Soeiro, Dyson, Lam, & Dazzi, 2005; 
Jiang et al., 2005). In the tumor microenvironment, MSCs promote tumor cell 
development and progression. MSCs in coculture with ovarian cancer cells, were 
shown to lead to altered biological function of gene clusters known for increased 
metastatic ability, proliferation and chemoresistance (Lis et al., 2012).  
 
Therapeutic strategies involving MSCs 
In contrast to embryonic stem cells, MSCs are free of ethical concerns and can be 
harvested from numerous tissue sources. These cells also show low 
immunogenicity and low teratoma risk. MSCs can differentiate into various cell 
lineages, they secrete soluble factors crucial for cell survival and proliferation, they 
can modulate immune responses, and migrate to sites of tissue injury (Figure 2). 
These characteristics have led to research directed toward the potential clinical 
application of MSCs. 
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Figure 2 Mesenchymal stem cell (MSC) properties qualifying them for therapeutic applications 
The properties of MSCs that make them useful as therapeutic vehicles. In addition 
to being able to differentiate into various tissues, MSCs exert a paracrine effect, are 
immunomodulatory, and show homing to tumor and sites of injury (Squillaro, Peluso, 
& Galderisi, 2015). 
 
In June 2015, 493 MSC-based clinical trials, either completed or ongoing, were 
available in the database of the US National Institute of Health. These trials include 
the application of these cells to treat hematological disease, graft-versus-host 
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disease, organ transplantation, diabetes, inflammatory diseases, and diseases in 
the liver, kidney, and lung, as well as cardiovascular, bone and cartilage, 
neurological, cancer and autoimmune diseases (Squillaro et al., 2015). 
 
Human MSCs do not induce alloreactivity in vitro or in vivo and hematopoietic stem 
cell transplantation recipients show reduced donor-specific immune responses after 
treatment with third-party MSCs (Sundin et al., 2009). 
The ability of MSCs to traffic from bone marrow or peripheral blood into damaged 
tissues to help effect repair makes them suitable for diverse clinical applications. 
Because these cells are involved in wound healing (Mackenzie & Flake, 2001), they 
support tissue regeneration after myocardial infarction (Kawada et al., 2004) and 
they promote restoration of bone marrow after myeloablative chemotherapy (Koc et 
al., 2000). Importantly, MSCs also home to tumor microenvironments that are seen 
as chronic wounds by the body (Nakamizo et al., 2005). 
 
Their general tropism for tumors and their efficient integration at the tumor site make 
MSCs an attractive therapeutic vehicle for the delivery of nanoparticles, oncolytic 
viruses or therapeutic genes to solid tumors. 
Tumor therapy with genetically modified MSCs 
MSCs have been used as vehicles to shuttle diverse therapeutic genes into critical 
parts of growing tumors. This has been referred to as a ‘Trojan horse’-based 
therapy approach (Bao et al., 2012). There are various strategies that have been 
used to genetically modify MSCs to target tumor biology (Table 1). 
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Table 1 Examples of genetically engineered MSCs targeting tumor biology 
Therapeutic gene 
system 
Examples Literature 
Proteins 
   - cytotoxic 
 
   - antiangiogenic 
-Tumor necrosis factor-
related apoptosis-inducing 
ligand (TRAIL) 
-human pigment 
epithelium-derived factor 
(PEDF) 
-NK4 (HGF antagonist) 
(Loebinger, Eddaoudi, 
Davies, & Janes, 2009) 
 
(Gao et al., 2010) 
 
 
 
(Kanehira et al., 2007) 
Immunostimulation -Interferon α 
-Interferon β 
-Interleukin-2 
 
-Interleukin-12 
(Ren et al., 2008) 
(Nakamizo et al., 2005) 
(Stagg, Lejeune, Paquin, 
& Galipeau, 2004) 
(Eliopoulos, Francois, 
Boivin, Martineau, & 
Galipeau, 2008) 
Gene-directed enzyme-
producing therapy 
(GDEPT) utilizing 
suicide genes 
-Thymidine kinase / 
Ganciclovir (GCV) 
-Cytosine deaminase  / 5-
fluorocytosine 
-Cytochrome P450 
isoforms / 
cyclophosphamide or 
ifosfamide 
-Tomato thymidine kinase 
1 / zidovudine  
(Zischek et al., 2009) 
(Kucerova, Altanerova, 
Matuskova, Tyciakova, & 
Altaner, 2007) 
 
(Chen et al., 2004) 
 
 
(Stedt et al., 2015) 
Sodium iodide 
symporter (NIS) gene 
131I, 123I, 125I, 124I, 
99mTc, 188Re, 211At 
(Dwyer et al., 2011; 
Knoop et al., 2011) 
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Gene-directed enzyme-producing therapy (GDEPT) systems have been used to 
engineer MSC to express ‘suicide genes’. These enzymes metabolize prodrugs into 
tumor toxic agents. High regional doses of a therapeutic drug are produced based 
on expression of the suicide gene. The cytotoxic drug effects not only the cells 
where the drug is produced, but also neighboring cells that do not express the 
enzyme. This is called ‘bystander effect’ (Altaner, 2008; Matuskova et al., 2010). A 
number of enzyme–prodrug systems have been developed, including the herpes 
simplex thymidine kinase (HSV-tk)/Ganciclovir (GCV), cytosine deaminase/5-
fluorocytosine, cytochrome P450 isoforms/cyclophosphamide or ifosfamide, and 
tomato thymidine kinase 1/zidovudine systems (Table 1). 
 
The choice of enzyme–prodrug system should be based on the characteristics and 
biology of the tumor of interest. The more directed the suicide gene expression is to 
the tumor milieu, the less potential damage to healthy tissue. In order to make the 
antitumor effect more selective, MSCs can be engineered to express therapeutic 
transgenes only when they are activated within tumor environment. This selective 
transgene expression can be achieved by the use of tissue specific gene 
promoters/enhancers that are induced only when the MSC respond to signals within 
the tumor setting (Bao et al., 2012). Several different gene promoters have been 
tested in this capacity (Conrad et al., 2011; Guo et al., 2007; Niess et al., 2011; 
Nyati et al., 2002; Yan et al., 2014). In an early example of this approach, the 
carcinoembryonic antigen (CEA) promoter was used to express suicide genes in 
CEA positive colon cancer cell lines in combination with different enhancer elements 
(Guo et al., 2007; Nyati et al., 2002). The promoter region of α-fetoprotein was also 
used as a regulator for tumor-specific soluble TRAIL expression by MSC in an 
animal model of HCC that showed significantly inhibited tumor growth (Yan et al., 
2014). Control of suicide gene expression has been demonstrated using the Tie2 
promoter/enhancer. Tie2 is a cell surface receptor for the proangiogenic factor 
angiopoietin-1. Tie2-HSV-tk MSCs were shown to successfully treat experimental 
tumors in murine models of pancreatic, breast and liver cancer (Conrad et al., 2011; 
Niess et al., 2011). A second approach has made use of the promoter for the human 
RANTES/CCL5 gene which has showed promising results in diverse animal models 
(Niess et al., 2015; Zischek et al., 2009). 
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The first clinical trials to evaluate genetically modified MSCs for tumor therapy are 
currently underway. These include HSV-tk expressed under the control of the 
CCL5/RANTES promoter in autologous MSCs, where therapy is initiated by addition 
of Ganciclovir (Niess et al., 2015). Phase I study protocols have also been published 
for MSCs genetically engineered to express Interferon β (ClinicalTrials.gov number 
NCT02530047) as well as using MSCs for the delivery of an oncolytic virus 
(ClinicalTrials.gov number NCT02068794), both studies targeting ovarian cancer. 
 
While these preclinical and clinical studies suggest a sound basis for this therapy 
approach, there are still obstacles that need to be overcome as we progress to the 
next stage of clinical development. After systemic intravenous application, many 
MSCs become entrapped in the microvasculature, especially of the lung. For intra-
arterial injection microthrombi formation are also a concern. Therefore, optimizing 
the mode of MSC application is still an important issue. 
Further research is also needed to better understand interactions between MSCs 
and the inflammatory, or tumor milieu. Localized therapeutic gene expression, in 
addition to enhancing tumor targeting, would also help to overcome potential side 
effects of MSC therapies. As canonical Wnt and Hedgehog signaling pathways are 
strongly linked to development and carcinogenesis, in this thesis gene promoters 
based on these pathways were evaluated for their selective activation by tumor-
derived signals. 
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Wnt signaling pathway 
Wnt signaling pathways are highly conserved across metazoans and have important 
roles in various biological processes, including embryonic development, tissue 
homeostasis and carcinogenesis (Logan & Nusse, 2004). In 1982 Nusse and 
Varmus identified the first member of the Wnt-ligand family in the mouse, called Int1 
(Nusse & Varmus, 1982). In 1987 Wingless was identified in drosophila as being 
essential for wing development (Cabrera, Alonso, Johnston, Phillips, & Lawrence, 
1987). Rijsewijk et al. reported a Drosophila homolog of the mouse int-1 gene and 
showed that this gene is identical to Wingless (Rijsewijk et al., 1987). In the 1990s 
the nomenclature was changed to Wnt (for Wingless-related integration site) to 
denote genes belonging to the int1/Wingless family, and the founding member int1 
was renamed as Wnt1 (Nusse & Varmus, 2012). Currently, there are three different 
intracellular Wnt signaling pathways described, the canonical/β-catenin dependent, 
the non-canonical/planar cell polarity (PCP), and the Ca2+ dependent pathway. All 
three initiate signaling cascades via a ligand binding to a Wnt receptor belonging to 
the frizzled (Fz) receptor family. The Wnt family is comprised of 19 secreted 
glycoproteins with crucial roles in the regulation of diverse processes, including cell 
proliferation, survival, migration and polarity, specification of cell fate, and self-
renewal in stem cells (Miller, 2002). 
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Figure 3 The canonical Wnt signaling pathway 
The protein β-catenin is a key player in canonical Wnt signaling activation. Generally 
it is identified in three distinct loci: at cellular adherent junctions, where it directly 
interacts with E-cadherin; in the cytosolic space; and in the nucleus. A): 
Unstimulated canonical Wnt signaling pathway. In most normal unstimulated adult 
cells, the Wnt/β-catenin pathway is inactive, and this is ensured by the absence of 
Wnt protein and the degradation of β-catenin. In the absence of Wnt ligand, β-
catenin is associated with the so-called destruction complex formed by glycogen 
synthase kinase–3β (GSK-3β), axin, and adenomatous polyposis coli (APC). 
Following phosphorylation of β-catenin, it is marked for ubiquitinylation and 
subsequently degraded by proteasomes. B): Stimulated canonical Wnt signaling. 
Wnt ligand binding to Frizzled (Fz) receptor and lipoprotein receptor–related protein 
(LRP) coreceptor activates Disheveled (Dvl), which inhibits GSK-3β. β-catenin 
accumulates and associates with T-cell factor and lymphoid enhancer factors 
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(TCF/LEF) in the nucleus to regulate target gene transcription. Secreted Frizzled-
related peptides (sFRPs) compete with Fz for Wnt ligand binding, thereby regulating 
signaling levels. Lithium (Li) inhibits GSK-3β, leads to downstrem Wnt signaling 
activation and therefore can be used to mimic canonical Wnt signaling (Etheridge, 
Spencer, Heath, & Genever, 2004). 
 
The canonical Wnt signaling cascade is shown in figure 3. Canonical Wnt signaling 
can be activated through various ligands, such as Wnt1, Wnt3, and Wnt3a that bind 
to one or more of the Fz receptors. Canonical Wnt signaling can be mimicked by the 
glycogen synthase kinase–3β (GSK-3β) inhibitor lithium chloride (LiCl) as it leads to 
downstream Wnt signaling activation. More recently several small molecules which 
modulate the signaling cascade have been identified (Kahn, 2014). Additionally, it 
has been suggested that in some cell types, stimulation with Wnt3a induces 
differentiation, for example during myogenesis and chondrogenesis (Bergwitz, 
Wendlandt, Kispert, & Brabant, 2001; Ridgeway, Petropoulos, Wilton, & Skerjanc, 
2000). 
 
The TCF/Lef1 transcription factors are the downstream targets of canonical Wnt 
signaling. These factors traffic to the nucleus and interact with β-catenin to 
moderate target gene expression. Because TCF/Lef1 recognizes a well-defined 
DNA binding site, it is possible to engineer luciferase-based Wnt reporters by 
multimerizing a binding site sequence (Korinek et al., 1997).  
 
Wnt signaling in MSC 
In 2004, canonical Wnt signaling was first described in human MSCs. An expression 
profile of Wnt signaling molecules in MSCs was initially identified using real-time 
PCR. MSCs express various Wnt ligands and Frizzled (Fz) receptors which suggest 
potential autocrine regulation of the pathway (Etheridge et al., 2004). Etheridge et 
al. detected expression of Fz receptors 2-6 in primary MSCs. Kolben et al. 
concluded that Fz 9 and Fz 10 are not expressed in MSCs while Fz 3 was 
expressed at low levels; the other Fzs exhibited high expression rates (Kolben et al., 
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2012). However, one has to consider that the mRNA expression profile does prove 
functional receptors on the surface (Table 2). 
 
Table 2 Overview of real-time PCR analysis to identify expression of Wnt signaling receptors, 
Frizzled (Fz), in primary human MSCs 
 (Etheridge et al., 2004) (Kolben et al., 2012) 
Fz1 - ✔ 
Fz2 ✔ ✔ 
Fz3 ✔ ✔ 
Fz4 ✔ ✔ 
Fz5 ✔ ✔ 
Fz6 ✔ ✔ 
Fz7 - ✔ 
Fz8 - ✔ 
Fz9 NA - 
Fz10 - - 
 
Human primary MSCs tested for the presence of Wnt genes using real-time PCR 
showed expression of Wnt2, Wnt4, Wnt5a, Wnt11 and Wnt16. Wnt1, Wnt2b, Wnt3, 
Wnt3a, Wnt6, Wnt7a, Wnt7b, Wnt8a, Wnt8b, Wnt10a, Wnt10b, Wnt14 and Wnt14b 
were not detectable (Etheridge et al., 2004). 
It has been proposed that low level stimulation using the canonical Wnt stimulators 
Wnt3a and LiCl, at a concentration of 1 and 4mM respectively, enhances the 
proliferation, and increases the ability of MSCs to transmigrate through transwell 
filters coated with human extracellular matrix. Moreover, neither osteogenic nor 
adipogenic differentiation of MSCs could be observed suggesting a differentiation of 
the MSC (Neth et al., 2006). Boland et al. also showed that in MSCs exposed to 
Wnt3a osteogenic differentiation is inhibited (Boland, Perkins, Hall, & Tuan, 2004).  
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Hedgehog signaling pathway 
Hedgehog (HH) signaling plays important roles in various biological processes, 
including embryonic development, tissue homeostasis, and regeneration. Through 
its regulation of epithelial-mesenchymal interactions, and subsequent control of 
organ system patterning and growth, HH signaling is critical for embryogenesis. 
Aberrant HH signaling is associated with cancer, notably basal cell carcinoma and 
medulloblastoma. 
The name Hedgehog derives from the short and “spiked” phenotype of the cuticle of 
the HH mutant drosophila larvae. Mutations in the HH gene were first described in 
1980 in drosophila (Nusslein-Volhard & Wieschaus, 1980), and in 1996 it was first 
associated with human cancer (Hahn et al., 1996). HH signaling is associated with 
many types of cancer – including skin, lung, brain, and gastrointestinal cancers as 
well as leukemia. There are canonical and non-canonical HH signaling cascades 
described. 
Canonical hedgehog signaling 
Key components of HH signaling include the ligands Sonic hedgehog (Shh), Indian 
hedgehog (Ihh), and Desert hedgehog (Dhh). Shh exhibits the widest tissue 
expression. Pachted1 (Ptch1) and Smoothened (Smo) are important regulators of 
HH signaling, negative and positive respectively; and the transcription factors 
downstream of the pathway are the glioma-associated oncogene (Gli) family 
members. Gli 1-3 - members of the zinc-finger containing protein family. Conserved 
HH targets include Gli1 and Ptch1, and their expression is commonly used to 
measure HH signaling activity. Gli1 functions as an activator, its transcription is 
induced by HH signaling and serves to amplify the HH signal. Hedgehog reporter 
plasmids have been generated through the multimerization of Gli protein binding 
sites (Kinzler & Vogelstein, 1990; Sasaki, Hui, Nakafuku, & Kondoh, 1997). 
Canonical HH signaling goes over PTCH-SMO-GLI axis (See figure 4). Despite 
intensive investigation, the exact mechanism is still unknown. Gli target genes 
include Cyclin-D1 (cell proliferation), ABCG2 (drug resistance), BCL2 (apoptosis 
resistance), Snail (EMT), WNT2 (Cell stem ness), VEGF (angiogenesis), TGFβ 
(immune modulation) (Jia, Wang, & Xie, 2015). 
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Figure 4 Mammalian canonical Hedgehog (HH) signaling pathway 
Transcription of HH target genes. a) In the absence of HH ligand, Pachted (Ptch) 
localizes in the cilia and represses Smoothened (Smo) activity by preventing its 
trafficking to the cilia. Glioma-associated oncogene (Gli) transcription factors are 
sequestered in the cytoplasm by several protein mediators, including protein kinase 
A (PKA), glycogen synthase kinase 3β (GSK-3β), casein kinase 1α (CK1-α) and 
suppressor of fused (SUFU). Gli undergoes proteasomal cleavage and the resulting 
repressor form (GLIR) translocates to the nucleus and inhibits translation of HH 
target genes. b) On ligand binding, Ptch is displaced from the cilia, thereby allowing 
ciliary accumulation and activation of Smo. Activated Smo orchestrates a signaling 
cascade that finally results in translocation of an activated form of Gli (GLIA) to the 
nucleus, where it induces expression of HH target genes (Amakye, Jagani, & 
Dorsch, 2013). 
Noncanonical hedgehog signaling 
By noncanonical, we collectively refer to cellular and tissue responses to the HH 
isoforms that are independent of transcriptional changes mediated by the Gli family 
of transcription factors (Robbins, Fei, & Riobo, 2012). However, the definition of 
noncanonical HH signaling is still heterogeneous. Because of an early agreement 
that all HH signaling involved Smo and Gli, noncanonical signal transduction is only 
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recently considered part of HH signaling. Noncanonical signaling routes have been 
associated with cancer, as they include genetic or expression changes of multiple 
oncogenes and tumor suppressors such as p53, KRAS, BRAF and PTEN.  
Hedgehog signaling pathway in MSC 
Relatively little is known about HH signaling in human MSC. This appears to be due 
to the differences in HH signaling in mammals and other animals, and to the 
relatively new interest in this pathway. 
In real-time PCR experiments it has been shown that human MSCs express HH 
ligands (SHH and IHH), the HH receptor (PTCH), the HH co-receptor (SMO), and 
several HH-responsive target genes (GLI1-3) (Lin et al., 2008). By contrast, Kobune 
et al. could not detect SHH, although its expression was detected in other cell types. 
They suggested that the expression of IHH in human MSCs may be more significant 
than the expression of SHH (Kobune et al., 2004). It has been proposed that 
recombinant Shh induces proliferation and differentiation of MSCs (Warzecha et al., 
2006).  
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Rationale of this study 
The central goals of this thesis were to investigate Wnt and Hedgehog signaling in 
the context of MSC biology, and in tumor milieu cross communication. To expand 
our understanding of these pathways in tumor stroma biology, and to provide insight 
into the future development of new molecular tools to refine the targeting of 
engineered MSC for tumor therapy (Figure 5). 
 
 
Figure 5 Overview of this thesis’ central research 
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Specific aims and scope 
Canonical Wnt and Hedgehog signaling are important pathways in embryogenesis, 
cell differentiation, and tumor development. A better understanding of their activity in 
within the tumor milieu can be exploited for therapeutic applications. Focusing on 
improving cellular therapies based on engineered mesenchymal stem cells as 
therapeutic delivery vehicle, the following research questions were addressed: 
• Does prestimulation of these pathways influence mesenchymal stem cells 
migratory potential towards tumor-derived signals? 
• Is it possible to activate Wnt or Hedgehog pathway specific promoters in 
experimental tumor milieu? 
• Is it possible to activate canonical Wnt and Hedgehog responsive elements 
stably transfected into mesenchymal stem cells based on the response of 
the MSC to signals within the tumor microenvironment? 
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Materials 
General information 
Permission for conducting gene experiments was obtained according to the ’Gesetz 
zur Regelung von Fragen der Gentechnik’ of June 20, 1990 (Bundesgesetzblatt, 
1990 I, page 1080). 
Studies using human material comply with the ethics permission obtained by PD Dr. 
Irene von Lüttichau. MSCs were harvested from donated bone marrow samples.  
 
Cell culture 
Media and supplements 
  
7-Aminoactinomycin D (7-AAD) Sigma-Aldrich, St.Louis 
Blasticidin InvivoGen, San Diego 
Bovine serum albumin (BSA) Invitrogen, Carlsbad 
CMFDA CellTracker™ Green 
Thermo Fisher, Waltham 
Collagen I bovine 5mg/ml Life Technologies, Carlsbad  
Doxycycline Hyclate Santa Cruz, Texas 
Dulbecco’s Modified Eagle Medium (DMEM) 
(1x), liquid,  Low glucose, contains sodium 
pyruvate 
Invitrogen, Carlsbad  
Dulbecco’s Modified Eagle’s Medium - low 
glucose 10x 
Sigma-Aldrich, St.Louis 
Dimethylsulfoxide (DMSO)  Merck, Darmstadt  
Dulbecco ́s PBS (without Ca2+ and Mg2+)  PAA Laboratories, Pasching  
Fetal calf serum (FCS)  Biochrom AG, Berlin  
L-Glutamin Thermo Fisher, Waltham 
Heparin-Natrium-25 000 Ratiopharm, Ulm 
HEPES, 1 M  Invitrogen, Carlsbad  
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Hygromycin B Roche, Basel 
Insulin solution human Sigma-Aldrich, St.Louis 
NaHCO3 (75g/l) Sigma-Aldrich, St.Louis 
NaOH Sigma-Aldrich, St.Louis 
Oxalacetic acid Fluka, Basel 
Penicillin/ Streptomycin (P/S), 100x  PAA Laboratories, Pasching  
Pyruvic acid Sigma-Aldrich, St.Louis 
RPMI 1640 Invitrogen, Carlsbad  
Trypan blue 0.4% Lonza, Basel 
Trypsin-EDTA in PBS, 1x PAA Laboratories, Pasching  
 
Cell lines and primary cells 
 
Cell line Description Source Medium Supplements 
Hek293 Human 
embryonic kidney 
cells 
M. Mack DMEM 10% FCS, 1% 
PS 
hbMSCAp172_1 
(MSC) 
Primary 
mesenchymal 
stem cells 
derived from 
human bone 
marrow of a 37-
year-old man 
Isolation 
and 
expansion 
company 
Apceth 
GmbH & Co 
DMEM 10% FCS, 1% 
PS, 2IE/ml 
Heparin-Natrium 
and 5% platelets 
or medium 
provided by the 
company 
Apceth GmbH & 
Co 
HT1080 Human 
fibrosarcoma cell 
line derived from 
a 35-year-old 
Caucasian man 
Rechts der 
Isar, C. 
Kopiz 
DMEM  10% FCS, 1% 
PS 
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HT29 Human colorectal 
adenocarcinoma 
(44-year-old 
caucasian 
woman) 
A. Griffioen DMEM 10% FCS, 1% 
PS 
HUH7 Human 
hepatocellular 
carcinoma 
cells (liver tumor 
from a 57-year-
old man) 
C. Spitzweg  DMEM 10% FCS, 1% 
PS 
L87/4 (iMSC) SV-40 
immortalized 
human 
mesenchymal 
stem cells 
derived from 
bone marrow (70-
year-old male 
donor) 
Pathology 
LMU 
RPMI 
1640 
10% FCS, 1% 
PS 
MonoMac6 
(MM6) 
Monocytic tumor 
cell line (isolated 
from a male 
patient with 
monocytic 
leukemia) 
L. Ziegler-
Heitbrock 
RPMI 
1640 
10% FCS, 1% 
PS, MEM 1x, 
Insulin 
900µg/ml, 1mM 
Oxalacetic acid, 
5mM Pyruvic 
acid 
SW480 Human colorectal 
adenocarcinoma 
(50-year-old 
male) 
A. Griffioen DMEM 10% FCS, 1% 
PS 
V54/2 (iMSC) SV-40 
immortalized 
Pathology 
LMU 
RPMI 
1640 
10% FCS, 1% 
PS 
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human 
mesenchymal 
stem cells 
derived from 
peripheral blood 
 
In this thesis L87/4 and V54/2 were referred to as immortalized mesenchymal stem 
cells (iMSCs). 
Experiments within the scope of this thesis with primary cells were conducted with 
human bone-marrow derived MSC in accordance with the ISCT criteria (Dominici et 
al., 2006). All primary MSCs used in this thesis were derived from the bone marrow 
of the same donor, the internal code name of these cells was hbMSCAp172_1. 
Bacteria 
One Shot® Mach1™ T1 Phage-Resistant Chemically Competent E. coli from 
Invitrogen, Carlsbad 
Buffer and solutions 
Molecular biology 
  
Buffers for DNA restriction enzymes, 10x NEB, Frankfurt 
Buffer TE, endotoxin-free Qiagen, Hilden 
Loading buffer for agarose gels, 6x 0.25% Bromphenol blue, 0.25% 
Xylen-Cyanol FF, 30% Glycerin 
Tris-borate-EDTA (TBE) buffer, 1x  90mM Tris, 2mM boric acid, 0.01 
M EDTA, ph 8.0 
1 kb DNA ladder Invitrogen, Carlsbad 
 
Microbiology 
  
Ampicillin solution 50mg/ml Ampicillin in 70% 
ethanol  
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Freezing solution for bacteria  132.3 mM KH2PO4, 21mM 
Sodiumcitrate, 3.7mM MgSo4*7 
H2O, 68.1mM (NH)2SO4, 
459.3mM K2HPO4*3 H2O, 35.2% 
Glycerin, autoclaved  
Chloramphenicol solution 34mg/ml Chloramphenicol in 
70% ethanol 
Kanamycin 10mg/ml Kanamycin in H2O 
LB medium 10g Bacto Tryptone, 10g NaCl, 
5g yeast extract, 1l Milipore 
water, autoclaved 
S.O.C. medium 0.5% yeast extract, 2% Bacto 
Tryptone, 10mM NaCl, 2.5mM 
KCl, 10mM MgCl, 10mM, 
MgSo4, 20mM glucose, sterile 
filtered 
Enzymes 
  
Gateway BP Clonase II Invitrogen, Carlsbad 
Gateway LR Clonase II Plus Invitrogen, Carlsbad 
Phusion DNA Polymerase NEB, Frankfurt  
Restriction enzymes NEB, Frankfurt 
T4 DNA Ligase with 10mM ATP NEB, Frankfurt  
Taq DNA polymerase  NEB, Frankfurt  
 
Primers 
Application Primer sequence (forward, reverse) 
Amplification of the 
Bar element from 
pN3-Bar-Gluc  
Fw TCTGACCCGTCGACGTAACCGTATTACCGCCATGC 
Rv TACCGATTGTACAGAGCTCGGTACCAAGCTTC 
Amplification of the Fw GGGGACAAGTTTGTACAAAAAAGCAGGCTTA-
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Bar and HH element 
and insertion of 
Gateway sites 
GCGGCCGCAATAAAAT 
Rv GGGGACAACTTTTGTATACAAAGTTGT-
ATGGTGGCTGGATAAGCT 
Amplification of Gli1 
and insertion of 
Gateway sites 
Fw GGGGACAACTTTGTATACAAAAGTTGTACCTCTG 
AGACGCCATGTTC 
Rv GGGGACCACTTTGTACAAGAAAGCTGGGTTCCCT 
TAGGAAATGCGATCTG 
Amplification of TCF7 
and insertion of 
Gateway sites 
Fw GGGGACAACTTTGTATACAAAAGTTGTAAGCTCG 
GATCCACTAGTAAC 
Rv GGGGACCACTTTGTACAAGAAAGCTGGGTTGCCT 
CAGAAGCCATAGAG 
Amplification of 
dTomato 
Fw GGGGACAACTTTGTATACAAAAGTTGTAATCATTT 
TGGCAAAGAATTGG 
Rv GGGGACCACTTTGTACAAGAAAGCTGGGTTTCTA 
GCTACCTAGCTAGTTTAC 
Amplification of 
WNT1 and insertion 
of Gateway sites 
Fw GGGGACAACTTTGTATACAAAAGTTGTACCTTCAC 
CATGGGGCTCT 
Rv GGGGACCACTTTGTACAAGAAAGCTGGGTTTCAC 
AGACACTCGTGCAGTAC 
Amplification of 
WNT3 and insertion 
of Gateway sites 
Fw GGGGACAACTTTGTATACAAAAGTTGTAATGGAG 
CCCCACCTGCT 
Rv GGGGACCACTTTGTACAAGAAAGCTGGGTTCTAC 
TTGCAGGTGTGCACG 
Amplification of 
WNT3A and insertion 
of Gateway sites 
Fw GGGGACAACTTTGTATACAAAAGTTGTAATGGCC 
CCACTCGGATAC 
Rv GGGGACCACTTTGTACAAGAAAGCTGGGTTCTAC 
TTGCAGGTGTGCACGTC 
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Plasmids and vectors 
Plamid Description Source Application 
GLI K12 (16419) Source of GLI 1 
element for HH 
reporter 
activation 
Addgene PCR template for 
GLI1 overexpression 
entry clone 
pCAG-Tomato Plasmid encodes 
for fluorescent 
protein Tomato 
M. 
Rosemann 
PCR template for 
tomato entry clone 
pcDNA6.2PLITRHYGRO Backbone with 
hygromycin 
selection 
C. Jäckel Destination vector in 
Gateway cloning LR 
reactions 
pcDNA-Gluc3-CMVMin-
Control 
Insert not 
responsive to 
Wnt or HH 
signaling 
C. Jäckel Control plasmid for 
reporter plasmids with 
Gaussia Luciferase 
read-out 
pcDNA3-HA-TCF1 
(40620) 
TCF7 sequence 
for Wnt reporter 
activation 
Addgene PCR template for 
TCF7 overexpression 
entry clone 
pCMV(CAT)T7-SB100 Plasmid encodes 
Sleeping Beauty 
Transposase 
Addgene Cotransfection in 
stable transfection of 
cells 
pENTR221-CMV Gateway 2 
fragment cloning, 
first fragment, 
entry clone 
encoding the 
CMV promoter 
C. Jäckel Gateway cloning 
WNT1, WNT3 and 
WNT3A expressing 
plasmids 
pENTR221-CMVTO Gateway 2 
fragment cloning, 
first fragment, 
entry clone 
C. Jäckel Gateway cloning 
TCF7 and GLI 
inducible expression 
vectors 
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encoding the 
doxycycline 
inducible CMV 
TO promoter 
pENTR223.1-WNT3 Canonical Wnt 
activator Wnt3 
encoding gene 
DNASU PCR template for 
WNT3 overexpression 
entry clone 
pLX304-WNT3a Canonical Wnt 
activator Wnt3a 
encoding gene 
DNASU PCR template for 
WNT3A 
overexpression entry 
clone 
pN3-BAR-Gluc Reporter plasmid 
for canonical 
Wnt signaling 
with Gaussia 
Luciferase read-
out 
P. Neth PCR template for the 
Bar CMV Min element 
for pcDNA Gluc3 
Bar(pN3) 
Wnt1 STOP (35868) Canonical Wnt 
activator Wnt1 
encoding gene 
Addgene PCR template for 
WNT1 overexpression 
entry clone 
 
Recombinant proteins and pathway modulators 
EGF, human Strathmann, Hamburg 
Recombinant human Wnt-3a  protein R&D, Minneapolis 
Lithium chloride Sigma-Aldrich, St. Louis 
 
Kits 
  
Endofree Plasmid Maxi Kit  Qiagen, Hilden  
BioLux Gaussia Luciferase Assay Kit NEB, Frankfurt 
Innuprep Plasmid Midi Direct Kit Analytik Jena, Jena 
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Innuprep Plasmid Mini Kit Analytik Jena, Jena 
Lipofectamine® 2000 Transfection Reagent ThermoFisher, Waltham 
Neon™ Transfection System 10µL Kit Invitrogen, Carlsbad 
QIAquick Gel Extraction Kit Qiagen, Hilden 
 
Laboratory equipment 
  
CO2 incubator New Brunswick™ Galaxy® 48 
R 
Eppendorf, Hamburg 
Fluorescence activated cell scanner 
FACSCalibur  
BD Biosciences, San Jose 
Heating stage for migration assay Ibidi, Martinsried 
Inverted fluorescence microscope DMIL Leica, Wetzlar 
Nano Drop ND-1000 Spectrophotometer PEQLAB Biotechnologie GmbH, 
Erlangen 
Neon® Transfection System  ThermoFisher, Waltham 
PCR machine Mastercycler pro Eppendorf, Hamburg 
Photo Camera for Leica DMIL  Jenoptik, Jena 
Photometer Lumat 9507 Berthold, Bad Wildbad 
 
Consumables 
  
FACS tubes BD Bioscience, San Jose 
Tubes, 5ml 75x12mm, PS (for luminometer) Sarstedt, Nümbrecht 
PCR tubes Eppendorf 0.2ml Eppendorf, Hamburg 
µ-Slide Chemotaxis 3D, ibiTreat Ibidi, Martinsried 
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Software 
Name Application Source 
Prism Statistical analysis and 
generation of graphs 
GraphPad Software, La 
Jolla 
ImageJ Analysis of migration 
assays and microscopy 
pictures 
National Institute of 
Health, USA 
CellQuest Analysis of FACS data BD Bioscience, San Jose 
Chemotaxis and 
Migration Tool – ImageJ 
Plugin 
Analysis of migration 
assays 
Ibidi, Martinsried 
Clone Manager 
Professional 9.2 
Planning cloning Sci-Ed, Denver 
pDraw32 Generation of plasmid 
maps 
Kjeld Olesen 
ProgRes Capture 
software 
Taking pictures Jenoptik, Jena 
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Methods 
Cell culture 
General cell culture 
Cells were cultured at 37°C and 5% CO2 in an incubator. Cell culture was conducted 
in a laminar flow hood to prevent contamination. All reagents were warmed to room 
temperature prior to use. 
For subculture, adherent cells were washed with PBS, detached using Trypsin-
EDTA solution until detachment of the cells was visible under the microscope, and 
then the reaction was stopped by adding double the volume of a medium containing 
10% FCS. After pelleting cells by centrifugation for 3min at 200g, they were 
resuspended in fresh medium and seeded into an appropriate cell culture vessel. 
Freezing and thawing of cells 
Cells were frozen in cryo-tubes with a freezing medium, containing the following: 
55% of their respective medium, 35% FCS, 10% DMSO. Subsequently, they were 
cooled to -80°C for at least 24h in an isopropanol container. For long-time storage, 
cells were put into the liquid nitrogen storage. 
To thaw cells, the frozen cell suspensions were rapidly warmed and were 
immediately transferred into a cell culture vessel filled with medium containing 10% 
FCS to dilute DMSO to a non-toxic concentration. The medium was changed within 
24h to remove DMSO completely. 
Counting cells 
To determine the number of cells per ml, a Neubauer counting chamber was used. 
An aliquot of the cell suspension was mixed 1:2 with Trypan blue solution (0.4%) in 
order to differentiate viable from dead cells. Then, the chamber was filled with the 
suspension and cells in all four corner squares were counted. The cell number was 
calculated, see equation 1.  
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𝑎𝑣𝑒𝑟𝑎𝑔𝑒  𝑐𝑒𝑙𝑙  𝑛𝑢𝑚𝑏𝑒𝑟  𝑝𝑒𝑟  𝑠𝑞𝑢𝑎𝑟𝑒   ∗ 10! ∗ 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 = 𝑐𝑒𝑙𝑙  𝑛𝑢𝑚𝑏𝑒𝑟  /𝑚𝑙 
Equation 1 Calculating number of cells using a Neubauer counting chamber 
 
Cell culture for primary mesenchymal stem cells 
Primary mesenchymal stem cells (MSC) were isolated form bone marrow aspirates 
taken in AKB Gauting. Isolation, expansion and differentiation assay of primary MSC 
(called hbMSCAp172_1) was conducted by the company Apceth GmbH & Co. 
Primary MSCs used in this thesis were all retrieved from one patient. For migration 
experiments, MSCs were cultured in medium on DMEM basis provided by the 
company Apceth GmbH & Co, the exact constitution being propriatory. 
For all other experiments, except for the migration assays, a medium consisting of 
DMEM, 10% FCS, 1% PS, 2IE/ml Na-Heparin and 5% platelets was used.  
The medium was changed every two to three days. 
 
Molecular biology 
Preparation of agar plates 
LB medium was prepared with mixing 10g of tryptone, 5g of yeast extract, 10g of 
NaCl in 950ml deionized water, adding 1N NaOH and 15g/L agar before 
autoclaving. When required, appropriate selection antibiotics were added after 
cooling (final concentration of Ampicillin 100µg/ml or Kanamycin 50µg/ml). The 
liquid agar was poured into petri dishes, let hardened and then the agar plates were 
stored in sealed plastic bags at 4ºC. 
Freezing and thawing of bacteria 
Bacterial glycerol stocks were established for long-time storage of E.coli strains. To 
this end, 900µl of an overnight culture were mixed with 100µl freezing solution for 
bacteria (10x) and frozen at -80ºC. For extraction of DNA, a liquid culture was 
inoculated with a small amount of frozen bacteria and a Midi or Maxi Prep was 
performed. 
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Test digestion of DNA 
DNA produced from Mini preps was digested in order to send the most promising 
clone for sequencing. Suitable test digests were identified using CloneManager 
Software (Sci-Ed, Denver) preferably finding enzymes cutting once in the backbone 
and once in the insert. We used 1µl enzyme per 1µg DNA per hour, but maximal 
10% of enzyme in the mix in total. DNA concentrations after Mini prep were 
estimated 30 to 100ng/µl. The double digest finder from New England Biolabs 
(www.neb.com) was used to identify the most suitable puffer and temperature.  
Separation of DNA fragments by gel electrophoresis 
Agarose gel electrophoresis was used to separate DNA fragments for analytical or 
preparative purposes. DNA fragments were separated by gel-electrophoresis at 160 
Volt. Gel containing a suitable percentage of agarose was chosen, for example 2% 
or 0.6% for fragments under 800 or over a 1000 base pairs, respectively. 
Gel extraction 
The QIAquick Gel Extraction Kit (Qiagen) was used according to the manufacturer’s 
protocol.  
Determination of DNA concentrations 
Nanodrop photometer was used to photometrically determine the amount of DNA in 
a sample. Nanodrop was initialized with 2µl RNAse free water and blanked with 2µl 
of the substance in which DNA was diluted. 
Transformation of competent E. Coli Mach1 
E.coli Mach1 were stored at -80°C and thawed on ice. After adding the DNA to the 
tube and gently mixing, incubation on ice was performed for 5 to 30min. After heat-
shocking at 42°C for 30sec, the tube was immediately transferred back on ice. 
Then, 250µl room temperatured S.O.C. medium was added, before shaking the tube 
horizontally for 1h at 37°C with 500rpm. The content of the tube was spread on a 
pre-warmed selective plate and incubated overnight at 37°C.  
Isolation and analysis of plasmid DNA from transformed bacteria 
Flasks with 50ml LB medium and the appropriate selection antibiotic were 
inoculated with E.coli bacteria from the glycerine stock (-80°C) or the backup plate 
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(4°C). See table 3 for the final concentration of the respective selection antibiotic in 
the LB medium. After incubation overnight on a warmed shaking device, the 
plasmids were isolated from E.coli bacteria using Qiagen Maxi or Midi Prep Kit. The 
EndoFree Plasmid MaxiKit was used according to the Protocol ‘Plasmid or Cosmid 
DNA Purification’. DNA was diluted in 250-400µl buffer TE. 
Table 3 Final concentration of selection antibiotic in LB medium used for inoculating E.coli 
Selection antibiotic Concentration 
Chloramphenicol 25µg/ml 
Ampicillin 120µg/ml 
Kanamycin 50µg/ml 
Spectinomycin 50µg/ml 
 
Polymerase chain reaction (PCR) 
PCR is used to amplify DNA. Suitable primers were ordered from Invitrogen 
LifeTechnologies and dissolved in the indicated amount of TE. Annealing 
temperature and elongation time were set for every PCR individually. See table 4 
and 5 for standard PCR settings. 
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Table 4 Standard polymerase chain reaction (PCR) settings 
Standard settings PCR  
98°C 3min Initialization step  
98°C 30sec Denaturation step 
Temperature dependent on primer 
30sec 
Annealing step  
72°C  and seconds per cycle 
dependent on length of the product 
Extension/elongation step 
72°C  10min Final elongation  
10°C Final hold  
 
Table 5 Standard PCR mix 
Standard PCR mastermix (per PCR tube 25µl) 
1:5 5x buffer Phusion HF Reaction Buffer 
200nM dNTPs 
400nM Forward primer 
400nM Reverse primer 
500ng Template DNA 
4.5 units Phusion HF Polymerase  
Add up to 225µl Aqua ad iniectabilia Braun 
If the PCR did not yield the expected bands, test PCRs were conducted adding 1-
3% DMSO. For further cloning steps 225µl total volume were suitable. 
Sequencing of DNA 
Samples were sent to GATC Biotech company for sequencing using Sanger’s 
method. 
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Cloning strategies & Plasmids 
Cloning was conducted in cooperation with Carsten Jäckel generally as described 
(Jackel et al., 2016). 
Gateway Cloning Technology 
Invitrogen’s Gateway Technology allows rapid and highly efficient transfers of 
heterologous DNA sequences into multiple vector systems. It is a universal cloning 
system based on the bacteriophage lambda site-specific recombination system 
which facilitates the integration of lambda into the E.coli chromosome.  
Gateway Technology enables efficient transfer of DNA-fragments between plasmids 
using a set of recombinant sequences and enzyme mixes. The general principle is 
as follows. First, a DNA fragment of interest is amplified using PCR with Gateway 
recombinant sites added to the primers. After separation of the DNA fragments by 
gel electrophoresis and gel extraction, 150ng of the DNA was used to perform the 
BP reaction. Next, the BP reaction was performed overnight, stopped and the 
preparation was transformed into E.coli which were then plated onto a LB plate. The 
next day, colonies were picked and Mini Preps were inoculated, also marking the 
clones on a backup LB plate. After DNA preparation, the DNA was digested and 
sent to the company GATC for sequencing. Subsequent LR reactions allow a 
combination of up to three different entry clones in one backbone yielding the final 
plasmid. After LR reactions, the preparation was again used to transform E.coli and 
DNA extraction followed. Cloning success was confirmed by test digests and 
sequencing. 
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Figure 6 Schematic overview of 2-fragment multisite Gateway cloning 
Every Gateway cloning process includes PCR, BP and LR reaction in order to 
obtain the final vector. 
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BP Reaction 
In a BP reaction, an entry clone is produced from an attB flanked PCR product and 
a donor vector. Depending on the experimental set-up, the suitable attB flanks were 
added to the PCR product and the correct donor vector was chosen. For example, 
in a 2-fragment reaction, the PCR product of the first fragment was attB1 and attB5r 
flanked and the pDONR221 P1P5r. The PCR product of the second fragment was 
flanked by attB5 and attB2 and pDONR221 P5P2 was used (Figure 6). The 
following components were pipetted together in a 1.5ml microcentrifuge tube: 150ng 
attB PCR product (1-7µl), 150ng pDONR vector and 1x TE buffer (filled up to 8µl). 
The enzyme BP clonase is temperature sensitive, after removing it from the -20°C 
storage, it was carefully shaken and centrifuged; a volume of 2µl was added to the 
microcentrifuge tube. After briefly vortexing and centrifuging, the reaction was 
incubated overnight at room temperature. The reaction was stopped by adding 1µl 
of Proteinase K and incubating at 37°C for 10min. Afterwards, Mach1 E.coli 
transformation followed, for vectors cloned within the scope of this thesis, with 
bacterial kanamycin selection. 
LR Reaction 
In a LR reaction, an expression vector is produced from one of up to four entry 
clones and a destination vector. The following components were pipetted together in 
a 1.5ml microcentrifuge tube: 40fmol destination vector, 20fmol per entry clone and 
1x TE buffer (filled up to 8µl). The following calculation is used to determine the 
needed amount of plasmid (Equation 2). 
𝑥  𝑓𝑚𝑜𝑙 ∗ 𝑦  𝑏𝑝 ∗
660𝑓𝑔
𝑓𝑚𝑜𝑙
∗
1𝑛𝑔
10!𝑓𝑔
= 𝑧  𝑛𝑔 
Equation 2 Coverting Femtomoles (fmol) to Nanograms (ng) 
x: amount of fmol one would like to use; y: amount of plasmid’s base pairs (bp); z: 
amount of plasmid needed for the LR reaction in ng. 
 
All LR reactions relevant for thesis were 2-fragment reactions. In this case, the entry 
clone for the first fragment contained attL1 and attR5 sites and the entry clone for 
the second fragment contained attL5 and attL2. Destination vectors were chosen 
according to the selection antibiotic for stably transfected cells, enabling 
cotransfections.  
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The enzyme LR Clonase II was vortexed briefly and 2µl were added to the 
microcentrifuge tube. After an overnight incubation at room temperature, the LR 
reaction was stopped with 1µl Proteinase K and incubated at 37°C for 10min. 
Afterwards Mach1 E.coli transformation followed, for our cloned vectors with 
bacterial ampicillin selection. 
Tetracycline-controlled transcriptional activation 
Tetracycline-controlled transcriptional activation was used for inducible gene 
expression where transcription is regulated through addition of the antibiotic 
tetracycline or its derivatives, for example doxycycline.  
For work in scope of this thesis, reporter plasmids that carry the TetRepressor and 
inducible expression constructs were tet-operated. After cotransfection of the 
reporter and the expression plasmid, doxycycline was added to activate gene 
expression. The system enabled the effects of specific genes stimulated with 
doxycycline to be compared to unstimulated cells. 
Reporter plasmids & other Wnt signaling 
pcDNA-Gluc3-CMVMin-Bar 
The TCF/LEF-reporter-plasmid measures β-catenin dependent expression in 
transfected cells. Canonical Wnt signaling is β-catenin dependent. Activity is 
measured using Gaussia luciferase reporter activity secreted into the growth media 
(Jackel et al., 2016). Gaussia luciferase is derived from the marine copepod 
Gaussia princeps; the luciferase catalyzes the oxidation of the substrate 
coelenterazine in a reaction that produces light and can be measured from the cells’ 
supernatant with a luminometer. 
In our reporter system, Gaussia luciferase is expressed and secreted when β-
catenin associated with TCF/LEF transcription factor after translocation into the 
nucleus. The Bar (β-catenin activated reporter) element was located directly in front 
of a minimal CMV promoter and consisted of 12 TCF/LEF responsive elements 
(AGATCAAAGG) divided by spacer sequences of 5 bases (Figure 7, (Jackel et al., 
2016). 
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The plasmid’s backbone was created by digesting the plasmid pcDNAGluc3_Rantes 
(available in our working group) with the enzymes BsrGI and XhoI. The Bar element 
was amplified from the plasmid pN3-BAR-Gluc (Peter Neth) using PCR. As the 
restriction sites from the enzymes SgrD1 and Xho1 were compatible, ligation of the 
backbone with the Bar element was possible. For ligation, 10x Buffer for T4 DNA 
Ligase with 10mM ATP and T4 DNA Ligase, and 1:3 molar ratio of backbone to 
insert were used.  
 
Figure 7 pcDNA-Gluc3-CMVMin-Bar, a canonical Wnt reporter plasmid 
In this canonical Wnt signaling reporter plasmid, the TCF/LEF responsive luciferase 
construct encodes the Gaussia luciferase reporter gene under the control of a CMV 
Minimal Promoter with Wnt responsive elements. Bar (β-catenin activated reporter) 
element uses 12 TCF/LEF binding sites; Min CMV: CMV minimal promoter, Gaussia 
Luciferase: CDS of the Gaussia Lucifrease; f1 ori: origin of replication; SV40: SV40 
promoter; Blasti: Blasticidin resistance gene; TetR: TetRepressor; SB:  Inverted 
terminal repeats for Sleeping Beauty 100 transposase. 
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pcDNA 6.2Hygro CMV TO TCF7 
This plasmid served as a positive control for the Wnt reporter plasmids, as it is an 
inducible expression construct of the transcription factor TCF7 (former name TCF-
1). When cotransfected with our reporter plasmids, expressing the TetRepressor, 
there is no expression of TCF7. Derepression through doxycycline leads to the 
induced expression. 
The plasmid was created using Gateway Cloning Technology. The Addgene 
plasmid 40620: pcDNA3-HA-TCF1 was used as a PCR template. In a 2-fragment 
multisite Gateway cloning reaction the entry clones CMV-TO and TCF7 were united 
in a destination vector expressing the hygromycin selection gene (Figure 8). 
 
Figure 8 Expression vector CMV-TO TCF7, an inducible Wnt signaling activator 
The expression vector CMV-TO TCF7 is a doxycycline inducible expression 
construct, serving as a positive control for the Wnt reporter plasmids. CMV TO: 
CMV promoter tet-operated; f1 ori: origin of replication; SV40 promoter; Hygro: 
Hygromycin resistance gene; SB:  Inverted terminal repeats for Sleeping Beauty 
100 transposase; Amp: Ampicillin resistance gene for bacterial selection. Gateway 
cloning sites attB1, attB5 and attB2. 
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Canonical Wnt stimulating plasmids 
In order to activate canonical Wnt signaling; WNT1, WNT3 and WNT3A gene 
sequences were obtained by PCR from the plasmids Wnt1 STOP, pENTR223.1-
WNT3 and pLX304-WNT3a respectively. 
 
The respective PCR product was combined with the donor vector pDONR221 P5P2 
in a BP Gateway cloning reaction yielding a suitable 2nd fragment entry clone for 2-
fragment cloning. In LR reactions the entry clone of the constitutively active CMV 
Promoter was combined with the respective WNT entry clones in a destination 
vector with Hygromycin selection (Figure 9). 
 
Figure 9 Expression vector CMV WNT3A, a plasmid constitutively expressing the WNT3A gene 
The expression vector CMV WNT3A constitutively expresses the WNT3A gene 
driven by a CMV promoter. The expression vectors CMV WNT1 and WNT3 contain 
the respective insert instead of WNT3A. f1 ori: origin of replication; SV40 promoter; 
Hygro: Hygromycin resistance gene for selection of transfected cells; SB:  Inverted 
terminal repeats for Sleeping Beauty 100 transposase; Amp: Ampicillin resistance 
gene for bacterial selection. Gateway cloning sites attB1, attB5 and attB2. 
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pcDNA6.2ITRHygro-BarCMVMin-Tomato (Bar-Tomato) 
This plasmid is a TCF/LEF-reporter-plasmid, β-catenin dependent activation leads 
to increased expression of the fluorescent protein Tomato in transfected cells. Peak 
absorption and emission are at 554 nm and 581 nm respectively. Tomato is a 
tandem dimer, equally photostable as mCherry fluorescent protein, but twice the 
molecular weight of mCherry. 
The reporter plasmid was generated via Gateway Multisite Cloning inserting two 
fragments, namely pENTR221-Bar CMV Min and pENTR221-Tomato.  
The entry clone pENTR221-Bar CMV Min was created by amplifying the Bar 
element from the plasmid pcDNA-Gluc3-Bar(pN3), and by adding the Gateway sites 
using PCR. Using gel electrophoresis the correct PCR product was identified as a 
599bp band, that was then cut out and extracted from the gel. In the BP reaction, 
the PCR amplicon was cloned into the pDONR221 P1P5r backbone. 
The plasmid pCAG-tomato was used as a PCR template for generating pENTR221-
tomato. Using gel electrophoresis, the correct PCR product was identified as a 
1523bp band, that was cut out and extracted from the gel. In the BP reaction, the 
PCR amplicon was cloned into the backbone pDONR221 P5P2. 
In an LR reaction the first fragment entry clone Bar, and the second fragment entry 
clone Tomato, were put together into the destination vector pcDNA6.2.ITRHygro, a 
vector expressing SB ITRs and a hygromycin selection gene (Figure 10). 
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Figure 10 Expression vector Bar-Tomato was created using the Bar and Tomato entry clone 
The expression vector Bar Tomato was created through Multisite Gateway Cloning. 
In a 2-fragment reaction the entry clones Bar and Tomato were united in the 
destination vector pcDNA6.2.ITRHygro. The expression vector Bar Tomato has 
Ampicillin (Amp) selection for bacteria and Hygromycin (Hygro) selection for 
transfected cells. Sleeping Beauty inverted terminal repeats (SB) enable an efficient 
transfection. Gateway cloning sites are marked with attB1, attB5 and attB2. 
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Reporter plasmids & other Hedgehog signaling 
pcDNA-Gluc3-CMVMin-HH(Hedgehog) 
The Gli responsive reporter plasmid is a reporter used for detecting Hedgehog 
signaling. The reporter plasmid possesses eight Gli binding sites with the sequence 
GACCACCCA. Gli activation leads to Gaussia Luciferase production and can be 
measured from the supernatant in the Gaussia Luciferase assay (Figure 11). 
  
The Gli responsive element was originally cloned from the commercially available 
plasmid Cignal GLI Reporter (luc) Kit: CCS-6030L (Qiagen), subcloned and, finally, 
classically cloned into our reporter plasmid (Jackel et al., 2016). 
 
 
Figure 11 pcDNA-Gluc3-CMVMin-HH, a reporter plasmid for Hedgehog signaling 
In this HH reporter plasmid, the Gli responsive luciferase construct encodes the 
Gaussia luciferase reporter gene under the control of a CMV Minimal Promoter. 
Hedgehog responsive via eight Gli binding sites; CMV: CMV promoter; Gaussia 
Luciferase: CDS of the Gaussia Lucifrease; f1 ori: origin of replication; SV40: SV40 
promoter; Blasti: Blasticidin resistance gene; TetR: TetRepressor; SB:  Inverted 
terminal repeats for Sleeping Beauty 100 transposase 
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pcDNA6.2PLITRHygro_Dest-CMV-TO-Gli1 
This plasmid served as a positive control for experiments studying Hedgehog 
signaling. It allows inducible expression of the transcription factor human glioma-
associated protein1 (Gli1). When cotransfected with reporter plasmids expressing 
the TetRepressor, there is no expression. Derepression through doxycycline leads 
to induced expression of Gli1. 
To obtain the Gli1 entry clone, the plasmid 16419: GLI K12 (Addgene) was used as 
a PCR template. In a 2-fragment multisite Gateway cloning reaction, the entry 
clones CMV-TO (Carsten Jäckel) and Gli1 were united a destination vector 
expressing the hygromycin selection gene (Figure 12). 
 
 
Figure 12 Expression vector CMVTO-Gli1, an inducible Hedgehog signaling expression 
construct 
The expression vector CMV-TO Gli1 is a doxycycline inducible expression 
construct, serving as a positive control for the Hedgehog (HH) reporter plasmids. 
CMV TO: CMV promoter tet-operated; f1 ori: origin of replication; SV40 promoter; 
Hygro: Hygromycin resistance gene; SB:  Inverted terminal repeats for Sleeping 
Beauty 100 transposase; Amp: Ampicillin resistance gene for bacterial selection. 
Gateway sites attB1, attB5 and attB2. 
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Control reporter plasmid 
pcDNA-Gluc3-CMVMin-Control, a 8435bp negative control plasmid was cloned as 
described (Jackel et al., 2016). The insert does not contain pathway specific 
responsive elements but was otherwise identical in construction to the Wnt or HH 
reporter plasmids with Gaussia Luciferase. Therefore, it was used as a control to 
differentiate if activation of the promoter and enhanced Gaussia Luciferase activity 
were an unspecific artifact or due to specific activation of the pathway responsive 
element. 
Transient and stable transfection of cells 
Lipofectamine2000 
Transient transfection of cells was conducted using Lipofectamine2000. 
Transfection with Lipofectamine2000 is based on the principle of micelle formation 
through the interaction between the cationic lipofectamine reagent and negatively 
charged nucleic acid. The complexes are taken up by the cells by endocytosis. DNA 
and lipofectamine concentration per well was established for each cell line. In order 
to transiently transfect L87 (iMSC) or Hek293 cells in a 96-Well plate, 0.2µl 
lipofectamine and 200ng DNA were diluted in 25µl Opti-MEM medium respectively. 
After a 5min incubation, DNA and lipofectamine were mixed and incubated 20min 
incubation at room temperature. Then, the mix was added to the 75% confluent cells 
which were seeded in 50µl medium with FCS. After 6-8h the medium was changed 
as lipofectamine also showed a toxic effect on cells. The next day the medium was 
changed again to stimulation medium. 
Electroporation/Nucleofection 
The mechanism of electroporation is not well understood. The current thought is that 
it creates small pores in the plasma membrane, allowing large molecules, like DNA, 
to enter the cytosol through diffusion. 
Therefore, 70-90% confluent cells were detached and counted. The needed amount 
of cells was put into a 1.5ml centrifuge tube and centrifuged for 1min at 7000xg. The 
pellet was resuspended in 10µl Puffer R and the plasmids, maximal 3µg in total per 
electroporation, were added. For stable transfections usually 1µg pCMV(CAT)T7-
SB100 and 2µg of the respective plasmid were transfected. The established 
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transfection conditions for the cell line were set on the screen and 3ml Puffer E were 
added to the container. Neon tips 10µl were used according to the manufacturer’s 
instructions and regenerated as described by Brees and Fransen (Brees & Fransen, 
2014).  Transfected cells were seeded in 25cm2 flasks with 5ml medium. Later, 24h-
48h after the transfection the medium was changed and the respective selective 
antibiotic for the plasmid was added. The concentration of the selective antibiotic 
was dependent on the type of antibiotic and the cell line. The lowest concentration 
of antibiotic was used where all not transfected cells died within 10 days for 
Blasticidin and Zeocin, and 14 days for Hygromycin. For primary cells, antibiotic 
concentrations were gradually raised to the determined final concentration. 
Neon electroporation transfection protocols were optimized for every cell line 
individually (Table 6 and 7). 
 
Table 6 Transfection protocols using Neon electroporator 
Cell line Voltage Width Pulses Cells per 10µl Puffer R 
hbMSC 1050V 30ms 2 1*106 
Hek293 950V 30ms 1 0.5*106 
L87 (iMSC) 900V 30ms 1 0,5*106 
V54-2 (iMSC) 900V 30ms 1 0,5*106 
 
Table 7 Selection antibiotic concentrations for primary hbMSCs and immortalized cell lines 
Cell line Blasticidin (µg/ml) Hygromycin (µg/ml) Zeocin (µg/ml) 
hbMSC  2 40  
Hek293 8 150 400 
L87 (iMSC) 6 200  
V54-2 (iMSC) 10 250  
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Stable transfection using Sleeping Beauty transposase 
Transposons, discovered in the 1940s by Barbara McClintock, are DNA segments 
that have the distinctive ability to move and replicate within genomes. The Sleeping 
Beauty (SB) transposon system is a non-viral gene transfer technology that uses a 
synthetic DNA transposon designed to introduce precisely defined DNA sequences 
almost randomly into the chromosomes of vertebrates. SB transposase inserts a 
transposon into a TA dinucleotide base pair in a recipient DNA sequence, resulting 
in a near-random integration profile. It is a reconstruction of an active vertebrate 
element from “dead” transposon fossils found in fish genomes. The gene of interest 
for integration into a genome has to be flanked by inverted terminal repeats (ITR) 
and the resulting plasmid has to be cotransfected with a transposase source, in 
scope of this thesis pCMV(CAT)T7-SB100 was used (Figure 13).  
Cells were stably transfected with Neon electroporator utilizing the respective 
plasmid with ITRs and 1µg of the plasmid pCMV(CAT)T7-SB100, Addgene plasmid 
# 34879.  
 
Figure 13 Plasmid used as transposase source pCMV(CAT)T7-SB100 
This plasmid encodes the gene of the Sleeping Beauty 100 (SB100) Transposase 
under the control of a CMV promoter. Chloramphenicol resistance gene for bacterial 
selection and a bacterial origin of replication (pBR322_ori) are present.  
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In vitro experiments 
Migration Assay 
In order to analyze motility and chemotaxis of primary mesenchymal stem cells 
ibidi® µ-slide Chemotaxis3D chambers and protocols were used.  
In this assay, 0.3x106 cells/ml were embedded in a collagen I matrix applied to the 
provided channel. Reservoirs were filled with HUH7 conditioned medium and control 
medium, creating a gradient. See figure 14 for the experimental set-up. After taking 
a picture every 15min for 18h, cell paths of 25 randomly selected cells were tracked 
manually using the ImageJ Manual Tracking plug in. Analysis was conducted using 
the Manual Tracking and Chemotaxis Tool plug in. Migration assays were 
conducted in cooperation with Alexandra Wechselberger.  
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Figure 14 Experimental set-up of a migration assay using ibidi® µ-slide Chemotaxis3D slides 
The gradient between the tumor conditioned medium (C100: concentration of 
chemokines 100%) and the control medium (C0: concentration of chemokines 0%) is 
shown. Cells embedded in a 3D matrix are exposed to the gradient and cell 
migration is observed through a microscope. (Picture modified from ibidi.com) 
 
Assay medium and collagen gel 
For the migration of primary cells, DMEM assay medium (DMEM, 1% BSA, 15mM 
HEPES) and DMEM 1mg/ml collagen were used. The gel with the collagen and a 
suspension of 0.6*106 cells in 12.5µl were carefully mixed 1:1 on ice and then 6µl 
were pipetted per slot. 
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HUH7 supernatant 
HUH7 supernatant is an established MSC chemoattractant source in our lab. To 
generate HUH7 cell supernatant, the cells were plated in a 10cm cell culture dish 
and grown until 100% confluency was reached. Then, the medium was changed to 
assay medium. After 48h the supernatant had been removed and centrifuged at 
200xg for 5 min. Aliquots of 250µl in 1.5 microcentrifuge tubes were stored at -20°C. 
Microscope settings 
Chemotaxis was monitored by time-lapse microscopy over an 18h period on a Leica 
DM IL microscope on a heated stage at 37°C. Pictures were taken in each 
experiment consistently every 15min with a Jenoptik ProgRes CCD camera.  
Chemotaxis parameters 
To quantify chemotaxis and migration, several values can be generated using the 
Chemotaxis and Migration Software Tool in the computer program ImageJ (National 
Institute of Health, USA). Around 25 cells were randomly selected and manually 
tracked (Figure 15). 
 
Figure 15 Microscopic picture of an ibidi® µ-slide Chemotaxis 3D with primary MSCs embedded 
in a 3D collagen I matrix with every colored track indicating migration of one cell 
For an 18h migration 72 pictures are taken and manually tracked using ImageJ 
software. Each colored track represents the migration of one cell during the entire 
experiment. 
Center of mass and Forward Migration Indices (FMI) both indicate the directed cell 
migration. The center of mass represents the averaged point of all cell endpoints. Its 
x and y values indicate the direction in which the group of cells primarily traveled. 
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The FMI represent the efficiency of the forward migration of cells, in our case in 
relation to the y-axis (Equation 3). The larger the index on an axis, the stronger is 
the chemotactic effect on this axis. For simplification, it is assumed that the y-axis is 
parallel to the direction of the chemotactic gradient.  
𝐹𝑀𝐼 = (𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒  𝑜𝑛  𝑦 − 𝑎𝑥𝑖𝑠)/(𝑎𝑐𝑐𝑢𝑚𝑢𝑙𝑎𝑡𝑒𝑑  𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒) 
Equation 3 The forward migration index (FMI) indicates the efficiency of forward migration 
 
The value of directionality is calculated by comparing Euclidean and accumulated 
distance (See figure 16). It indicates the directness of the cell trajectories. A 
directionality of 1 equals a straight-line migration from start to endpoint. 
 
Figure 16 Nomenclature of distances in migration experiments 
An exemplary track of a cell is shown (cell path = accumulated distance; blue). It is 
assumed that the y-axis is parallel to the direction of the chemotactic gradient (CM: 
Gradient of tumor conditioned medium). Euclidean distance indicates the most 
direct connection between starting and endpoint. In comparison to the accumulated 
distance which indicates the total distance a cell has traveled. The parameter 
directionality compares Euclidean with accumulated distance. 
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Statistical analysis 
Migration data was analyzed with Prism software using the Mann-Whitney-test, an 
unpaired test for non-parametric data. 
Gaussia Luciferase Assay 
The principle of the luciferase reporter makes use of a secreted version of the 
marine copepod Gaussia princeps’ protein; this luciferase catalyzes the oxidation of 
the substrate coelenterazine in a reaction that produces light. Gaussia activity is 
assayed from supernatant of cells which have been transfected with Gaussia 
Luciferase expressing plasmids using a luminometer. The luminescence measured 
is proportional to the amount of enzyme produced, which reflects the level of 
transcription. In reporter plasmids the activation of a target gene was driving the 
production of the Gaussia Luciferase. 
A BioLux Gaussia Luciferase Flex Assay Kit from New England BioLabs was used 
according to the manufacturer’s manual. Per sample, 0.5µl substrate, 8µl stabilizer 
and 50µl assay puffer were mixed and incubated at room temperature protected 
from light for 25min. In 5ml tubes 50µl of the mix and 20µl of the cells’ supernatant 
were incubated together for a minimum of 45sec. Measurements on the photometer 
were conducted with an integration time of 10.0 sec. 
Coculture experiments 
Once reporter cells were adherent, tumor cells or MM6 cells were added. If not 
indicated differently, 104 reporter cells were seeded in a 96 well the day before 
adding cells for coculture. A 96 well contained cells in 100µl medium with 5% FCS. 
Gaussia Luciferase was measured 48h after tumor cells were added. 
Using microscopy, cell viability was confirmed before measuring Gaussia 
Luciferase. In order to precisely differentiate living from dead cells, 10x Höchst-PI 
was added to the supernatant 1:10 and viability was checked with fluorescent 
microscopy. 
Supernatant experiments 
Supernatant was obtained from 100% confluent tumor cells, which were washed 
with PBS and cultured in DMEM without FCS for three days. Conditioned 
supernatant was centrifuged at 350xg for 5min to remove cells and cell debris. 
Aliquots were frozen and stored at -20°C. 
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MM6 supernatant was generated in MM6-medium without FCS (RPMI 1% PS, MEM 
1x, Insulin 900µg/ml, 1mM Oxalacetic acid, 5mM Pyruvic acid). After three days 
cells were centrifuged and supernatant was frozen. Concentrated supernatant was 
obtained with Amicon centrifugal filters (10kDalton, protein concentration and 
desalting) and centrifugation till flow-through was seen (around 20min). 
Reporter cells were seeded in a 96 well with a total of 100µl volume. The next day 
the medium was changed to 100µl conditioned supernatant. Gaussia Luciferase 
was measured 24h afterwards. 
Fluorescence microscopy of cells 
Fluorescence microscopy is a form of light microscopy based on the physical effect 
of fluorescence. Fluorochromes are activated by light of a specific wavelength and 
emit light of another wavelength; specific filters secure that only the emitted light is 
observed. 
Pictures were taken as seen through the ocular and exposure time was set 
accordingly, gain was set to 1. Bright field and fluorescent pictures were taken of a 
representative spot of the cell culture plate and overlays were generated in ImageJ. 
In parallel, to detect and exclude autofluorescence artifacts the probe was also 
examined in other filters. In order to avoid photobleaching cells were exposed to 
fluorescent light as short as possible. Filter Y3 (BP 610/75) was used for detecting 
the red fluorescent protein Tomato (Emission maximum: 581 nm). 
Fluorescence activated cell scanning (FACS) analysis 
FACS is a laser-based technology and was used for detection of fluorescent 
proteins in stably transfected cells. FL-protein expression was measured on a BD 
FACS Calibur. Debris and dead cells were excluded by 7-Aminoactinomycin D (7-
AAD) staining and appropriate gating. Fluorescent protein Tomato was detected in 
FL2 and 7-AAD in FL3, a combination of Tomato and 7-AAD made manual 
compensation necessary. 
Spheroid Assay 
Tumor spheroids are heterogeneous cellular aggregates characterized by hypoxic 
regions and necrotic centers that are thought to better reflect complex tumor 
biology. 
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Many adherent cell lines tend to attach to each other when lacking the possibility to 
grow in monolayer. Tumor spheroids, 3D in vitro tumor models, were generated 
using the hanging-drop method. Tumor cell suspensions of 2.4*104 cells/ml were 
seeded in drops of 25µl in a petri dish lid, flipped, put on the bottom filled with PBS 
and cultured in these hanging drops for three days. Spheroids with a diameter of 
around 300µm were harvested. 
The addition of MSC to HUH7 spheroids was conducted following a standardized 
protocol (Rühland, 2014). In a volume of 50µl 1.5*104 cells per spheroid were mixed 
in a 1.5ml microcentrifuge tube. After shaking for 30min at 37°C, cells that had not 
attached were washed away. Spheroids were then seeded back into hanging drops 
and incubated for 24h. Subsequently, they were fixed in 100µl 4% 
paraformaldehyde, washed PBS and stored at 4°C until imaging. 
Finally, 3D imaging was conducted in Martinsried using light sheet microscopy.  
Invasion assays, imaging and analysis were conducted in cooperation with the 
biological doctoral student Svenja Rühland. 
Statistical analysis 
Migration assays were conducted in duplicate and repeated, yielding four times 25 
tracks per condition which were analyzed applying Mann-Whitney test. 
Gaussia Luciferase experiments were conducted at least in triplicate, repeated and 
the analysis of a representative experiment is shown. Graphs indicate mean ± 
standard deviation. Data was analyzed using student’s t-test for Gaussian 
distributed data. 
Statistical significance was marked in the graphs with p-values < 0.05 (*), < 0.01 (**) 
and < 0.001 (***) as determined by the software Prism (GraphPad Software, La 
Jolla). 
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Results 
Directed migration of MSCs towards tumor-derived signals 
To optimize the therapeutic application of MSCs, it is important to better understand 
their migratory behavior. Tumor tropsim has been demonstrated in vitro and in vivo 
for MSCs, however the general efficiency can vary between preparations, and some 
MSCs also migrate to other organs. This can limit therapeutic potential of modified 
MSCs as healthy tissue can also be damaged by application of the therapeutic 
agent. Preactivation of MSCs with pathway modulators, so-called MSC priming, is a 
relatively easy and fast way of potentially influencing MSC migration and tropism.  
Wnt and Hedgehog (HH) signaling crosstalk at a molecular level and can be seen 
as part of a larger regulatory network controlling fundamental aspects of cell biology 
(Angers & Moon, 2009). Those pathways play key roles in development and 
alterations can lead to cancer. We then set out to determine if these pathways can 
influence directed MSC migration.  
 
HUH7 tumor conditioned medium is a chemoattractant for MSCs (Endaya et al., 
2017; Schmohl et al., 2015), this was confirmed by the observation that the center of 
mass of all cell trajectories was shifted towards higher concentrated tumor 
conditioned medium after 18h of migration, which is indicated by the orange dot on 
Figure 17. Moreover, the Rayleigh p-values of the medium control groups under 
0.05 indicate that the cells were inhomogeneously distributed, also suggesting 
distribution according to a chemogradient (Figure 18f and 19f). 
 
After prestimulation of primary MSCs with the canonical Wnt activator Wnt3a, the 
directed migration towards tumor conditioned medium was measured. Either 
75ng/ml or 400ng/ml Wnt3a was added to MSCs in serum free medium for 24h or 
48h. Then, an in vitro migration assay was conducted using ibidi µ-slides. Cell 
migration was followed in a 3D collagen I gel in response to a gradient of 
conditioned HUH7 media for 18h.  
Center of mass or the Forward Migration Index (FMI) both indicate directed cell 
migration. The yFMI represents the efficiency of the forward migration of the cells in 
relation to the y-axis. The larger the index on an axis, the stronger the chemotactic 
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effect along this axis. For simplification, it is assumed that the y-axis is parallel to the 
direction of the chemotactic gradient (Figure 16). The yFMI was found to be 
significantly larger after prestimulation for 24h with 75ng/ml Wnt3a (p=0.255), and 
for 48h with 75ng/ml (p<0.001) and 400ng/ml (p=0.0022). Wnt3a as compared to 
the unstimulated control. The results show that Wnt3a prestimulation can 
significantly enhance MSC chemotaxis towards tumor conditioned medium (Figure 
17).  
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Figure 17 Visualization of cumulative data from short-term migration experiments 
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Each track on the graph represents a path of an individual cell, the endpoint being 
accentuated. Black tracks follow the gradient of HUH7 conditioned medium (CM) to 
higher concentrations, red tracks indicate cell migration towards lower 
concentrations. The center of mass is marked with an orange dot. Cells were 
tracked for 18h after being exposed to a) control medium, 75ng/ml Wnt3a 
conditioned medium for b) 24h or c) 48h and 400ng/ml Wnt3a conditioned medium 
for d) 24h or e) 48h. 
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Figure 18 Statistical analysis of cumulative short-term migration data 
Migration parameters from MSCs prestimulated with either 75ng/ml Wnt or 400ng/ml 
Wnt3a, abbreviated as 75 and 400 on the graphs, for 24h and 48h are shown. 
Medium control graph a-e) shows results from the control group of various 
experiments which are not shown. 
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a) Statistical analysis of the forward migration index on y-axis (yFMI) shows 
significant differences between pretreated group and control which suggests that 
Wnt3a prestimulation enhances MSCs chemotaxis towards tumor conditioned 
medium. b) Directionality is calculated by dividing Euclidean by accumulated 
distance. Wnt3a prestimulation for 24h or 48h with 75ng/ml enhances directionality 
significantly which means cell trajectories become more direct from start- to 
endpoint. c)-e) Wnt3a prestimulation influences velocity, accumulated and 
Euclidean distance. f) Rayleigh p-values indicate how homogeneous the distribution 
of cells is; p-values under 0.05 suggest an inhomogeneous distribution, for example 
because cells followed the chemotactic gradient and distribution is not random 
anymore. (Mean ± standard deviation, Mann-Whitney-test) 
 
In the short-term migration studies, an enhanced directed MSC migration was 
observed after Wnt3a prestimulation. To investigate whether these changes of 
migratory behavior were permanent or transient a long-term migration experiment 
was then conducted. 
After stimulation with 75ng/ml or 400ng/ml Wnt3a for 24h or 48h cells were cultured 
for two to three more cell passages, and a new migration assay was performed. No 
memory effect was observed, meaning enhanced chemotactic parameters FMI and 
directionality, were no longer enhanced by prestimulation in long-term (a week or 
more after stimulation), in contrast to what was seen in short-term (24-48 hrs) 
(Figure 19a-b and 18a-b). 
Thus, the influence of Wnt3a priming on MSCs on directed migration appears to be 
transient and reversible.  
 
 
 
Results Ι 
 
66 
 
Figure 19 Statistical analysis of cumulative long-term migration data 
Migration parameters obtained from a migration assay with MSCs two to three 
passages (a week or more) after being stimulated with either 75ng/ml Wnt or 
400ng/ml Wnt3a, which is abbreviated on the graph with 75 and 400 respectively, 
for 24h or 48h are shown. Medium control graph a-e) shows results from the control 
group of various experiments which are not shown. 
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a) The enhanced migratory potential of Wnt3a pretreated MSCs is temporary and 
reversible. Statistical analysis of the forward migration index (FMI) shows no 
significant differences between pretreated group and control which suggests the 
chemotactic enhancing effects from Wnt3a prestimulation which is observed in the 
short-term migration, is not detectable anymore. b) Directionality is calculated by 
dividing Euclidean by accumulated distance. Directionality of cell paths is not 
different between pretreated MSCs and control. c)-e) Wnt3a prestimulation 
influences velocity, accumulated but not Euclidean distance. f) Rayleigh p-values 
indicate how homogeneous the distribution of cells is; p-values under 0.05 suggest 
an inhomogeneous distribution, for example because cells followed the chemotactic 
gradient and distribution is not random anymore. (Mean ± standard deviation, Mann-
Whitney-test) 
 
Reporter cells 
Canonical Wnt and HH signaling are highly conserved pathways involved in 
carcinogenesis and differentiation. The ligands activating those pathways can be 
found in tumor environments and can condition cells within the tumor. We then 
sought to determine if the Wnt or HH response of MSC to tumor derived ligands 
could lead to activation. The central question was to determine if the synthetic 
promoters are candidates for refined gene-directed enzyme-based MSC therapy.  
 
Canonical Wnt- and Hedgehog-responsive reporter iMSCs 
As a first step, Sleeping Beauty transposon-based reporter plasmids with the 
respective synthetic promoter were generated, and stably transfected into iMSC. 
Gaussia Luciferase secretion into the growth medium was used as a read-out for 
pathway activation/reporter promoter activity. 
The functionality of the reporter constructs was verified by stable cotransfection of 
an expression construct with a reporter plasmid in iMSCs. The doxycycline inducible 
expression constructs TCF7 (Expression vector CMV TO TCF) and Gli1 (Expression 
vector CMV TO Gli1) were used to activate canonical Wnt and HH reporter cells 
respectively. Various doxycycline concentrations were tested to identify the optimal 
stimulation levels which were found between 0.1 and 1µg/ml doxycycline. At higher 
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concentrations, beginning at 5µg/ml, toxic effects on cells were observed. 
Stimulation with 1µg/ml doxycycline for 72h of iMSCs stably transfected with Bar-
TCF7 showed 12.3 fold increase relative to the unstimulated control, whereas HH-
Gli cells showed a 2.9 fold level of induction (Figure 20). 
 
Figure 20 Test of doxycycline inducible overexpression constructs stably transfected in iMSC 
Stably engineered iMSC established using a reporter plasmid cotransfected with 
respective doxycycline (dox) inducible transcription factor construct. Various dox 
concentrations were then tested, 1µg/ml yielding highest fold-change to 
unstimulated control and was therefore used in subsequent experiments. Gaussia 
Luciferase was measured 72h after stimulation. a) canonical Wnt reporter (Bar) with 
TCF7 overexpression. b) Hedgehog reporter (HH) with GLI overexpression. (mean + 
standard deviation; student’s t-test; RLU = relative luciferase unit) 
 
Stably engineered iMSCs containing either the Bar or control plasmids were 
stimulated with different concentrations of recombinant human Wnt3a or lithium 
chloride (LiCl). Lithium chloride`s toxic effects on cells was observed at 50mM, 
being more severe in cells stimulated without FCS than with FCS present (Data not 
sown). Stimulation with Wnt3a and LiCl was observed in Wnt-responsive reporter 
cells and no stimulation was found in cells stably transfected with the control 
plasmid. Hereby, unspecific activation of the reporter cells, for example through 
upregulated metabolism, was excluded (Figure 21a). 
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Figure 21 Stably transfected Bar iMSCs can be stimulated with Wnt3a or lithium chloride 
a) In contrast to iMSC stably transfected with a control plasmid, iMSC Bar reporter 
can be stimulated with Wnt3a or lithium chloride (LiCl), thereby excluding unspecific 
stimulation. b) Gaussia Luciferase measurement at 24h, 48h and 72h after 
stimulation with 400ng/ml Wnt3a, showed the highest stimulation at 48h with 5.6 
fold-change to the unstimulated control. (mean + standard deviation; student’s t-test; 
RLU = relative luciferase unit) 
 
Stably transfected iMSCs were stimulated with 400ng/ml recombinant human Wnt3a 
for 24h, 72h or 96h. Gaussia Luciferase measurement after 48h showed the highest 
fold change to the unstimulated control with 5.6 fold, compared to 3.7 and 5.2 fold at 
24h and 96h respectively (Figure 21b). 
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Figure 22 Functionality of the Wnt protein producing plasmids WNT1, WNT3 and WNT3A is 
shown in Wnt reporter iMSC 
Transiently transfected with WNT1, WNT3 or WNT3A plasmid iMSC Bar are 
activated compared to mock transfected control. Gaussia Luciferase was measured 
48h after the transient transfection with lipofectmine. As an additional control mock 
transfected iMSC Bar were stimulated with the recombinant protein Wnt3a. (mean + 
standard deviation; student’s t-test; RLU = relative luciferase unit) 
 
Constitutively WNT1, WNT3 or WNT3A gene expressing plasmids were cloned to 
produce control Wnt proteins. After transient transfection into iMSC Bar reporter 
cells, all constructs lead to significantly increased Gaussia Luciferase signal, 
verifying their functionality (Figure 22). The proteins Wnt1, Wnt3 and Wnt3a are 
known as classical activators of the canonical Wnt signaling pathway. In addition, 
expression constructs transiently transfected into iMSC showed enhanced Wnt 
signaling.  Suggesting that, these plasmids can also be used as positive controls for 
Wnt reporter cells.  
 
Canonical Wnt and Hedgehog-responsive reporter primary MSCs 
The functionality and suitability of the reporter plasmids for stable transfection in 
immortalized cell lines and primary MSCs was verified. 
 
 
Results Ι 
 
71 
Primary MSCs were stably transfected using Neon electroporation. Induction of the 
expression plasmid TCF7 with 1µg/ml doxycycline lead to increased Bar reporter 
activity and confirmed the functionality of the reporter. Moreover, the presence of 
the canonical Wnt signaling cascade was verified using recombinant human Wnt3a 
added to the supernatant. Combination of doxycycline derepression and Wnt3a 
stimulation showed additive effects. The optimal time point for Gaussia luciferase 
measurement after doxycycline stimulation was found at 72h, drawn from fold-
change to control (Figure 23). 
 
 
Figure 23 Primary MSCs can be stably cotransfected with the Wnt reporter (pcDNA-Gluc3-
CMVMin-Bar) and inducible expression plasmid (Expression vector CMV-TO TCF7) 
Functionality of the reporter cells, the inducible expression construct TCF7 and the 
canonical Wnt signaling cascade in stably transfected primary human bone marrow 
derived MSCs (hbMSC) was verified. Stably cotransfected hbMSCs with Wnt 
signaling reporter (Bar) and doxycycline inducible TCF7 expression construct 
showed increased reporter activity upon stimulation with 1µg/ml doxycycline (dox). 
Stimulation with recombinant human Wnt3a (Wnt3a) was possible, verifying the 
presence of the canonical Wnt signaling cascade in hbMSCs. Gaussia Luciferase 
was measured a) 48h and b) 72h after stimulation. (mean + standard deviation; 
student’s t-test; RLU = relative luciferase unit) 
 
Primary hbMSC HH reporter cells stably transfected with the doxycycline inducible 
expression construct Gli1, showed increased Gaussia Luciferase signal upon 
stimulation with 1µg/ml doxycycline. The ideal time point for Gaussia Luciferase 
measurement after doxycycline stimulation was found at 72h with 1.8-fold induction 
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compared to unstimulated control. Thereby constructs’ functionality in hbMSC was 
shown (Figure 24). 
  
 
Figure 24 Primary MSCs can be stably transfected with the Hedgehog reporter (pcDNA-Gluc3-
CMVMin-HH) and inducible expression plasmid Gli1 (Expression vector CMV-TO Gli1) 
Functionality of the Hedgehog (HH) reporter and the inducible Gli1 expression 
plasmid were verified in primary hbMSC. Stably transfected hbMSC HH reporter 
cells with doxycycline inducible Gli1 expression constructs show induction upon 
stimulation with 1µg/ml doxycycline (dox). Fold-changes compared to unstimulated 
control constitute 1.5 fold after 48h and 1.8 fold after 72h. (mean + standard 
deviation; student’s t-test; RLU = relative luciferase unit) 
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Coculture experiments 
In the next set of experiments, we sought to determine if the Wnt or HH response in 
MSC could be activated by contact with cells representing leukocytes within the 
tumor milieu such as macrophages, or by tumor cells. 
 
The influence of tumor coculture on reporter plasmids stably transfected into 
Hek293 was tested, because those cells were easy to transfect as well as to culture 
and therefore, were used in proof of principle experiments. Secondly, iMSC reporter 
cells were cocultured with tumor cell lines to investigate the tumor milieu`s influence 
on those reporter cells. 
 
Bar and HH reporter plasmids stably transfected into Hek293 were stimulated in 
coculture and with supernatant of SW480, HT29, HUH7 and HT1080 tumor cell line 
and MM6, a macrophage cell line (Refer to page 25-27 for more information about 
the cell lines). Significantly enhanced reporter activity was observed in Hek Bar and 
Hek HH reporter cells. In contrast, stably transfected iMSC Bar or iMSC HH did not 
show increased reporter activity in either coculture (Figure 25). 
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Figure 25 Coculture of the cell lines Hek293 or iMSC with HH or Wnt reporter with tumor and 
macrophage cell lines 
Hek293 (Hek) cells stably transfected with either Wnt (Bar) or Hedgehog (HH) 
reporter can be stimulated in coculture with SW480, HT29, HUH7 and HT1080 
tumor cell lines and the MM6 macrophage cell line. As positive control in Bar 
reporter cells 400ng/ml Wnt3a was used. b) iMSC HH coculture showed lower 
Gaussia Luciferase signal, whereas d) iMSC Bar showed no significant difference 
from control. In the experimental set-up, 104 reporter cells were added the day 
before 4*104 tumor or macrophage cells were added to a 96 well. Gaussia 
Luciferase was measured after 48h of coculture. (mean + standard deviation; 
student’s t-test; RLU = relative luciferase unit) 
 
In Hek HH an increasing reporter activity is found with increasing MM6 coculture cell 
numbers (Figure 26). Two different iMSC cell lines were tested to emphasize the 
finding and to exclude specific problems with one immortalized cell line. Neither in 
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peripheral blood derived nor in bone marrow derived stably transfected iMSC HH 
stimulation could be observed (Figure 26). 
 
 
Figure 26 Hek293 and two different iMSC lines in coculture with different MM6 cell numbers 
Black columns represent reporter cells only as control, either 5 000 or 10 000 were 
seeded the day before MM6 cells were added. Grey columns represent coculture of 
the respective HH reporter cell line with 1*104, 2*104 or 4*104 MM6 cells. Dose 
dependent stimulation was observed in stably transfected Hek HH cells, but not in 
stably transfected iMSC HH, neither peripheral blood derived cells nor bone marrow 
derived cells. (mean + standard deviation; student’s t-test; RLU = relative luciferase 
unit) 
 
As iMSCs are bigger in size than Hek293 cells, also lower cell numbers were tested 
to exclude that competition between reporter and MM6 cells obscures mild effects. 
However, also when 103 reporter cells were seeded the day before coculture with 
2*103, 4*103 or 6*103 MM6 or HT1080 cells, no stimulation was observed in reporter 
iMSC (Figure 27). Because HT1080 and MM6 cells showed higher stimulation of 
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Hek HH reporter activity than other cells tested in coculture, those two cell lines 
were used. 
 
 
Figure 27 No stimulation of iMSC Wnt or Hedgehog reporter cells in coculture with low cell 
number of HT1080 or MM6 cells can be observed 
Coculture with lower cell numbers was conducted in order to exclude competition for 
space was obscuring stimulatory effects. In the experimental set-up, 103 reporter 
cells were seeded the day before 2*103, 4*103 or 6*103 HT1080 or MM6 cells were 
added to a 96 well. Gaussia Luciferase was measured after 48h. No stimulation 
neither of iMSC Bar nor iMSC HH was observed. (mean + standard deviation; 
student’s t-test; RLU = relative luciferase unit) 
 
Supernatant experiments 
We next sought to determine if soluble factors secreted by tumor cells or 
macrophages lead to activation of canonical Wnt or HH response in MSC. 
The reporter cells were then exposed to supernatants of various tumor cell lines and 
a macrophage cell line to investigate whether soluble factors were mediators of the 
stimulation observed in coculture experiments. In contrast to coculture experiments, 
supernatant experiments mimic tumor milieu without competition for space and 
regardless of differences in proliferation rates among cell lines, and therefore, can 
be better controlled. 
 
 
Results Ι 
 
77 
Reporter cells were stimulated with tumor cell line supernatant of SW480, HT29, 
HUH7 and HT1080. Hek HH and Hek Bar cells showed significant increase in 
reporter activity (Figure 28a, c). In contrast to iMSC reporter cells, which did not 
show a significant difference from control (Figure 28b, d). Human epidermal growth 
factor (EGF), in a concentration of 25ng/ml was able to stimulate Hek HH reporter 
cells, but not iMSC HH (Figure 28a, b). 
 
 
 
Figure 28 Various tumor cell supernatants (SW480, HT29, HUH7 or HT1080) added to the cell 
lines Hek293 or iMSC with HH or Wnt reporter 
Hek293 (Hek) and iMSC reporter cells were cultured in tumor cell line conditioned 
serum free DMEM medium for 24h, before measuring Gaussia Luciferase. a) Hek 
Hedegehog reporter (HH), b) iMSC HH, c) Hek Wnt reporter (Bar) and d) iMSC Bar. 
Significant increase in reporter activity was observed in Hek reporter cells, but not in 
iMSCs. As a positive control for the Bar reporter stimulation with 400ng/ml Wnt3a 
was used. Human epidermal growth factor (EGF), in a concentration of 25ng/ml was 
able to stimulate Hek HH reporter cells, but not iMSC HH. (mean + standard 
deviation; student’s t-test; RLU = relative luciferase unit) 
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Supernatant of the macrophage cell line MM6 was able to stimulate Hek HH 
reporter cells and supernatant 8-fold concentrated via Amicon (10kDalton centrifugal 
filters) increased the effect (Figure 29a). Hek Bar cells only showed significantly 
enhanced reporter activity with concentrated supernatant (Figure 29c). In contrast, 
iMSC HH or Bar reporter showed decreased reporter activity in presence of 
concentrated supernatant (Figure 29b, d). 
 
Figure 29 MM6 macrophage supernatant added to the cell lines Hek293 or iMSC with HH or Wnt 
reporter 
a) Hek Hedegehog reporter (HH), b) iMSC HH, c) Hek Wnt reporter (Bar) and d) 
iMSC Bar were cultured in MM6 conditioned serum free MM6 medium for 24h, 
before measuring Gaussia Luciferase. Whereas MM6 and 8-fold concentrated MM6 
conditioned medium stimulated Hek HH, and concentrated medium Hek Bar cells, 
iMSC reporter cells even showed decreased reporter activity. As a positive control 
for Bar reporter cells 400ng/ml Wnt3a was used. (mean + standard deviation; 
student’s t-test; RLU = relative luciferase unit) 
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Coculture and supernatant experiments in primary cells 
In order to investigate whether the observed effects in iMSC were due to issues 
related to an immortalized MSC cell line or generally applicable to primary MSCs, 
select coculture and supernatant experiments were repeated with primary human 
bone marrow derived MSC (hbMSC). Unfortunately, stably transfected reporter 
hbMSC were difficult to generate and culture and only a view experiments could be 
conducted with the limited cell numbers. Primary Bar reporter cells could not be 
activated in coculture nor with supernatant of HT1080 cells. Viability of cells was 
checked through light and fluorescence microscopy after adding Höchst-PI (Figure 
30c). Höchst is a living cell dye highlighting nuclei of eucaryotic cells and PI is a 
dead cell stain, penetrating membranes of dying or dead cells.  
HH reporter cells cocultured with HT1080 showed decreased reporter activity 
compared to unstimulated control (Figure 31). 
 
Figure 30 Primary Wnt responsive (Bar) MSCs cannot be stimulated in coculture with HT1080 
cells nor with its supernatant  
Primary human bone marrow derived mesenchymal stem cells (hbMSC) Wnt 
reporter (Bar) cells could not be activated in a) coculture with 4*104 HT1080 cells 
nor with b) HT1080 supernatant. Positive control with 400ng/ml Wnt3a shows 
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significantly enhanced reporter activity. (mean + standard deviation; student’s t-test; 
RLU = relative luciferase unit). c) Höchst-PI was added to the coculture to 
differentiate living from dead cells using fluorescent microscopy. A view dead cells 
were detected with PI, however, Höchst showed many living cells. Scale bar 100µm. 
 
Figure 31 Primary Hedgehog responsive (HH) MSCs in coculture with HT1080 show decreased 
signal 
Primary bone marrow derived mesenchymal stem cells (hbMSC) Hedgehog (HH) 
reporter cells were seeded the day before 2*104 HT1080 cells were added. No 
stimulation was observed, instead a significantly decreased reporter signal was 
detected. (mean + standard deviation; student’s t-test; RLU = relative luciferase unit) 
 
Wnt-responsive fluorescent cells 
To investigate the tumor milieu and its potential effect on MSCs, reporter cells with a 
fluorescent protein read-out were established to measure promoter activity of stably 
transfected MSCs while invading a 3D tumor model, a so-called spheroid. Tumor 
spheroids are heterogeneous cellular aggregates characterized by hypoxic regions 
and necrotic centers that are thought to better resemble complex tumor biology. 
MSC undergo invasion of the spheroid based on the activation status of the MSC, 
and can induce transgene expression based on the ability of the reporter MSC to 
respond to specific signals present in the spheroid environment. 
Utilizing light sheet microscopy, fluorescence of cells, thus representing canonical 
Wnt signaling activity, could be measured once cells had invaded the spheroid. 
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Establishment of this assay should help in the characterization of tumor 
microenvironments in general, and whether these promoters could be useful for the 
induced expression of therapeutic transgenes in the context of malignancies. 
 
Only one cell in one spheroid, out of eight spheroids in total, showed a Tomato 
positive iMSC, which was most likely a Tomato positive cell even unstimulated 
rather than representing canonical Wnt pathway activity in the tumor milieu. 
However, it can be concluded that Tomato fluorescence could be deteced and did 
not interfere with 5-Chloromethylfluorescein Diacetate (CMFDA) labelling of iMSCs 
(Figure 32). 
 
Figure 32 Stably transfected Bar-Tomato iMSC invade a HUH7 tumor spheroid 
Stably transfected iMSCs Bar-Tomato invade a HUH7 spheroid. Tomato 
fluorescence could be detected in CMFDA labelled iMSCs using lightsheet 
microscopy. However, the one Tomato positive cell found in one out of 8 spheroids 
is rather artefact than indicating Wnt signaling activity. Beats were used to calculate 
a 3D image from 2D images taken from five different angles (signal outside the 
speroid in Tomato and composite, red in the composite). 
 
Reporter cell function was confirmed by prestimulation with the canonical Wnt 
activator Wnt3a, as well as LiCl ,and measuring  flourescence using FACS. 
In FACS analysis, strong induction of reporter cells was observed under stimulation 
with 25mM LiCl, yielding 70.2% Tomato positive cells and a y-mean of 474, the 
more physiologic Wnt signaling activator Wnt3a showed a moderate induction of 
2.6% Tomato positive cells and a y-mean of 96 (Figure 33). Dead cells were 
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identified using 7-AAD staining and were excluded by appropriate gating. LiCl 
concentrations over 45mM yielded an increased number of dead cells, especially 
when stimulation was performed without FCS. (Data not shown.) 
 
Primary bone marrow derived MSCs stably transfected with the Bar-Tomato reporter 
plasmid show dose-dependent induction under Wnt3a stimulation in FACS analysis. 
Neither HUH7 nor HT1080 tumor cell supernatant show increased reporter activity 
(Figure 34). 
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Figure 33 FACS analysis of stably transfected Bar-Tomato iMSC under different stimulation 
conditions 
FACS analysis of iMSCs stably transfected with the Bar-Tomato plasmid after 
stimulation with b) 400ng/ml recombinant human Wnt3a, c) 4mM or d) 25mM lithium 
chloride (LiCl) for 24h. e) The histogram shows the distribution of Tomato 
flourescence intensity its cell count. Dead cells and cell debris were excluded by 7-
AAD staining and appropriate gating.   
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Figure 34 FACS analysis of primary MSC stably transfected with Bar Tomato reporter under 
different stimulation conditions 
FACS analysis of stably transfected primary human bone marrow derived 
mesenchymal stem cells (hbMSC) with a canonical Wnt reporter (Bar) and Tomato 
read-out. Dose dependent induction under Wnt3a stimulation was observed, 
however, neither HUH7 nor HT1080 supernatant stimulated reporter cells.  
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Discussion 
Influencing MSC migration and tumor tropism 
MSCs are actively recruited to sites of inflammation, injury and tumor. Once MSCs 
reach the tumor, they can act as progenitors for cells that become part of the tumor 
stroma, and thus are generally thought to promote tumor progression. Genetically 
modified MSCs have been adapted for use as therapeutic vehicles for the delivery 
of therapy genes into tumor environment. Wnt and Hedgehog (HH) signaling are 
important pathways in development as well as differentiation and aberrant signaling 
is linked to carcinogenesis. Therefore, we sought to investigate their potential roles 
in the directed MSC migration towards tumor-derived signals.  
 
To test this question, various migration assays were applied. These included 
transwell migration assays, also called modified Boyden chambers, where the 
transmigrated cells are quantified at a certain time point. More recently, and in 
comparison, µ-Slides Chemotaxis 3D now allow cell tracking through microcopy 
using pseudo video analysis, and therefore, can provide more detailed information 
at various time points. This assay is very efficient for measuring the migration of 
adherent cells. Parameters that can be determined in this method include the 
distance traveled, as well as cell distribution from which the forward migration index 
(FMI) and directness can be calculated. Zengel et al. proposed that the generation 
of a stable gradient for a longer time period, as well as tracking over long distances, 
is also possible with this assay (Zengel et al., 2011). For the migration experiments 
in this thesis, µ-Slide Chemotaxis 3D, ibdiTreat were used.  
Conditioned medium (CM) generated from a hepatocellular carcinoma cell line 
(HUH7) was used as a tumor relevant chemoattractant. Hepatocellular carcinoma 
has been shown to secrete diverse factors that can influence MSC recruitment. 
These include; VEGF, PDGF, TGFβ, MCP-1, IL-8, TNFα, SDF-1 and HGF, as 
reviewed by Bayo et al. (Bayo et al., 2014).  
The chemoattractant’s effect on MSCs was confirmed by changes in the center of 
mass (Figure 17, orange dot) that shifted towards the higher concentrated “tumor” 
conditioned medium. Inhomogeneous cell distribution was also indicated by a 
Rayleigh p-value under 0.05 (Figure 18f and 19f). 
 
 
Discussion Ι 
 
86 
 
MSC heterogeneity is thought to represent a potential obstacle for the application of 
these cells in a clinical setting. It has been proposed that even though MSCs are 
cultured under ISCT criteria, they remain somewhat heterogeneous. Thus, a subset 
of those cells may have better homing abilities in a given setting. Within individual 
experiments performed here, relatively high standard deviations for the FMI were 
observed, as some cells migrated more efficiently towards tumor CM than did 
others. However, repeated experiments, and an expanded number of tracked cells 
allowed us to identify significant differences in migratory behavior of the cell 
population. Four slides with 25 tracked cells each were generally analyzed per 
condition to identify significant differences between different parameters. 
 
MSC experiments need to be carefully planned and well controlled, as many factors 
influence MSC viability as well as migration. For example, it has been suggested 
that increased culture confluency impairs migration (De Becker et al., 2007). 
Therefore, hbMSC confluency was controlled and documented in order to enhance 
comparability  within, and between experiments. 
 
MSC are relatively plastic cell types. They have the capacity to differentiate and  are 
sensitive to their growth and expansion environment. It has been suggested that a 
pre-activation, or induced differentiation, may alter their general tropism for tumor-
derived signals. In this regard, the Hedgehog and Wnt signaling pathways are 
strongly associated with the differentiation status of cells, as well as their ability to 
undergo migration. To study this in more detail, preconditioning experiments using 
Wnt-relevant signals were performed. Human recombinant Wnt3, a classical 
activator of canonical Wnt signaling, was used for preconditioning of primary human 
MSCs. A low and high concentration of the recombinant agent was used, namely 
75ng/ml and 400ng/ml. We and others have observed in Gaussia Luciferase 
experiments that higher concentrations did not yield better stimulation of Wnt-
responsive cells. The low concentration was used to avoid potential negative 
feedback loops due to excessive stimulation.  
The distinction between chemotaxis and chemokinesis is important when 
interpreting migration data. Chemotaxis is defined as the directed migration of cells, 
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for example towards a gradient of chemokines secreted by tumor cells. By 
comparison, chemokinesis is defined as a general increase in the random motility of 
a cell. Therefore, for the accurate interpretation of migration data, various 
parameters need to be considered. An altered forward migration index (FMI) and 
directness, which both can be calculated, suggest that the stimulus exerts 
chemotactic effects, whereas altered velocity alone could be interpreted as 
enhanced chemokinetic effects. The effects of Wnt3a prestimulation on MSC 
migration are chemotactic, as the FMI and directness show significantly enhanced 
migration towards tumor CM in prestimulated MSCs. Consequently, Wnt3a 
prestimulation is suitable for improving MSCs’ chemotaxis towards tumor-derived 
signals (Figure 18a-b). 
 
Unfortunately, it was not possible to study the potential effect of Sonic Hedgehog 
preactivation on MSC migration. The only commercial sources of recombinant 
protein required extremely high concentrations of the protein to see effects, that 
made the experiments cost prohibitive. Attempts to generate a Shh producing 
plasmid and cell line failed. 
 
Wnt signaling has been linked to the potential differentiation of cells. We then 
sought to determine if the changes seen with Wnt3a stimulation persisted in the 
treated cells. To do this, primary human MSC were again stimulated with high and 
low levels of the recombinant protein, and the cells were then passaged for several 
weeks, and then subjected to migration analysis. The general improvement of 
migration seen in the short term (several days) could not be demonstrated after 
culturing cells for two to three passages and are thus temporary and fully reversible 
(Figure 19). 
 
In conclusion, Wnt3a preconditioning of MSCs influenced their directed migration 
towards tumor-derived signals significantly in the short-term (Figure 18). Moreover, 
the stimulatory effect was temporary and reversible, which on one hand, may be 
seen to help limit potential side effects of MSC pretreatment (Figure 19). However, 
further validation in vivo is necessary to evaluate the significance of these findings 
for potential therapeutic applications. 
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Wnt and HH responsive transgenes 
Canonical Wnt and HH signaling are highly conserved pathways involved in 
development and carcinogenesis (Takebe et al., 2015). The ligands activating those 
pathways can be found in tumor environments, and can in turn condition cells within 
the tumor environment. Investigating whether synthetic promoters designed to 
measure canonical Wnt and HH signaling in MSC can be activated by tumor-derived 
signals was used to determine if this biology was applicable for use in the tumor-
induction of MSC transgenes. 
Reporter plasmids and transfection 
Reporter plasmids were generated using specific synthetic promoters with secreted 
Gaussia Luciferase used as a read-out for pathway activity to efficiently measure 
the status of canonical Wnt and HH signaling pathways in MSC. 
There are various strategies that have been developed for transducing MSCs, 
including virus-mediated methods (such as lentivirus, retrovirus or adenovirus) and 
plasmid-mediated methods (Dwyer, Khan, Barry, O'Brien, & Kerin, 2010; Zischek et 
al., 2009). Viruses as gene-delivery vehicles are somewhat controversial for 
potential human application as they show integration-site preferences that may 
increase chances of adverse effects, the need for extensive purification and quality 
control to prevent replication-competent virus, the costs associated with their 
production and handling, and finally, the requirement of S2 safety laboratories for 
viral-based engineering (Aronovich, McIvor, & Hackett, 2011). The various 
transfection methods described within this thesis were plasmid-mediated using 
either electroporation or nucleofection. A plasmid-based vector platform was 
specifically developed for these and related studies (Jackel et al., 2016). The 
plasmids were designed to include transposase-based gene transfer technology 
using the Sleeping Beauty (SB) transposon for stable transfections (pCMV(CAT)T7-
SB100, Addgene). The SB system allowed efficient transfection and near-random 
integration in the host cell genome. Primary MSCs were found to be efficiently stably 
transfected using our vector platform and the SB system (Jackel et al., 2016). 
Functionality of the Wnt and HH reporter plasmids generated were validated by 
transfecting them with a second doxycycline inducible expression construct 
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containing coding sequences for either the TCF7, or GLI1 transcription factors, 
respectively, in the target cells. Derepression of the TetRepressor by 1µg/ml 
doxycycline yielded the highest Gaussia-Luciferase-to-unstimulated-control-ratio 
after 72h. Functionality was verified in Hek293 (Jackel et al., 2016), iMSC and MSC 
reporter cells (Figure 20, 23 and 24). 
Canonical Wnt pathway activation 
There are various means available to activate canonical Wnt signaling in vitro, for 
example, the use of recombinant Wnt proteins, supernatants from Wnt producing 
cell lines, or the use of lithium chloride (LiCl). More recently, additional small 
molecule modulators of canonical Wnt signaling have been described (Kahn, 2014). 
An excellent overview of these agents can be found online at 
https://web.stanford.edu/group/nusselab/cgi-bin/wnt/smallmolecules.  
It was first described in the 1990s that treatment with lithium could activate 
canonical Wnt signaling through inhibition of the GSK-3β protein kinase (Hedgepeth 
et al., 1997; Stambolic, Ruel, & Woodgett, 1996). Lithium also exerts effects on 
other pathways, such as inhibition of inositol monophosphate (IMPase) which 
causes a reduction in inositol levels and thereby prevents generation of inositol tris-
phosphate (IP3) (Berridge, Downes, & Hanley, 1989). Thus, data generated with LiCl 
treatment may not result exclusively from canonical Wnt signaling. However, it is 
inexpensive relative to recombinant protein, and was therefore used as an initial 
screen for the functionality of Wnt reporter cells. Pathway activation was observed in 
Wnt reporter cells stimulated with medium concentrations (20-25mM) of LiCl as 
compared to the addition of recombinant Wnt proteins. Depending on the cell type, 
LiCl toxic effects were observed at varying concentrations. FACS analysis showed 
increased dead cell numbers as identified with 7-AAD at 4mM LiCl for primary 
MSCs, whereas iMSCs and Hek293s tolerated higher concentrations. LiCl 
stimulation in 10% serum-containing medium showed less dead iMSCs compared to 
stimulation without serum, suggesting that LiCl is less toxic in medium with serum 
(Data not shown). 
As compared to what has been described by others, the experiments detailed here 
did not show enhanced Wnt reporter activity upon stimulation with 4mM LiCl (Kolben 
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et al., 2012). This might be due to less sensitive reporter cells, maybe because of 
higher background of the plasmid’s promoter or lower transfection efficiency. 
To expand our Wnt-based reagents, Wnt producing expression plasmids were 
cloned using the Gateway cloning technology and our vector platform developed in 
part for the present study (Jackel et al., 2016). Coding sequences for the canonical 
Wnt activators Wnt1, Wnt3 and Wnt3a, were put under control of the constitutively 
active CMV promoter. Cotransfection of these plasmids into iMSC Bar reporter cells 
yielded reporter activity induction validating that increased expression of WNT1, 
WNT3 and WNT3a could induce canonical Wnt signaling in the iMSC (Figure 22). 
These plasmids are currently being used to further evaluate functionality of Bar 
reporter cell lines. 
Hedgehog pathway activation 
The HH reporter cells used in this thesis were comprised of a multimer of Gli-
responsive elements linked to a minimal promoter driving a reporter gene. Sonic 
hedgehog (Shh) is the best studied ligand for the HH pathway, however, we 
refrained from stimulating reporter cells with commercial recombinant Shh as very 
high, nonphysiologic concentrations were necessary in our preexperiments (as 
suggested by the manufacturer), and the cost of broad studies was cost prohibited. 
Shh’s physiologic function is dependent on posttranslational modifications and, 
therefore, the source of the recombinant protein plays an important role. 
Functionality of the reporter plasmid was verified by cotransfection with an inducible 
GLI expression construct, but unfortunately no positive control for the whole 
signaling cascade was readily available. However, substances that could activate 
our HH reporter cells were identified. These included tumor and macrophage cell 
line coculture and conditioned supernatant, and the use of human epidermal growth 
factor (EGF). The HH pathway can be triggered by many intracellular signals, 
including those mediated by TGF-β, KRAS–MAPK/ERK, PI3K–AKT, IGF, TNF-α 
induced mTOR/S6K1 activation, and inactivation of hSNF5 (Dennler et al., 2007; 
Jagani et al., 2010; Z. Ji, Mei, Xie, & Cheng, 2007; Riobo, Lu, Ai, Haines, & 
Emerson, 2006; Wang et al., 2012). It has been proposed that EGF actions’ are 
mediated by sequential activation of the Shh and Akt signaling transduction pathway 
(Stepan et al., 2005). 
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By contrast, iMSC HH could not be activated neither by EGF nor by tumor coculture 
or supernatant, but could be activated by the induced expression of the Gli 
transcription factor – positive controls. This suggests that these substances may 
trigger different signaling cascades in the Hek and iMSC lines which differ in origin 
and function. Hek cells are human embryonic kidney cells transformed by 
adenovirus. The iMSCs used in this thesis were L87/4 and V54/2, are SV40 large T-
antigen immortalized MSCs derived from bone marrow or the peripheral blood 
respectively. 
It is possible that EGF is a mediator of the effects exerted by macrophage cell line 
coculture and supernatant. However, more studies, for example with pathway 
specific inhibitors added to supernatant experiments, are necessary to better 
understand the mechanisms.  
Wnt and HH responsive reporter MSCs in experimental tumor milieu 
The tumor microenvironment is complex. It is comprised of various normal cells in 
addition to the tumor cells. These normal cells include; fibroblasts, cells associated 
with vessels, macrophages and immune cells. The milieu also consists of different 
zones with varying concentrations of chemokines and growth factors, hypoxia and 
pH. Due to this complexity, it can be difficult to model it in vitro. In this study, 2D 
coculture studies, or supernatants harvested from tumor or macrophage cell lines, 
and 3D invasion assays were applied to characterize the potential activation of Wnt 
and Hedgehog reporters in engineered MSCs.  
 
To this end, the tumor cell lines SW480 (colorectal adenocarinoma), HT29 
(colorectal adenocarinoma), HUH7 (hepatocellular carcinoma), and HT1080 
(fibrosarcoma) were chosen after a review of the literature for their general 
association, and potential to activate either HH or Wnt signaling in the engineered 
MSC. The presence of the secreted HH ligand, Shh, has been shown by RT-PCR 
and by Western analysis for SW480 and HT29 (Mazumdar et al., 2011). For HT29, 
cell surface expression of HH ligands was further validated using FACS analysis 
(Yauch et al., 2008). Wnt signaling was described using a Wnt-reporter plasmid in 
SW480 (Pasca di Magliano et al., 2007) and Wnt ligand expression was detected in 
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HT1080 (Capovilla, 2013). HUH7 as a representative hepatocellular carcinoma cell 
line, was also included for subsequent experiments. 
To investigate the potential influence of the tumor milieu on MSC-reporter induction, 
2D coculture was established. The various cell lines tested had different growth 
characteristics. Viability of the cells was checked through light microscopy, and by 
use of Höchst-PI to differentiate living from dead cells in fluorescent microscopy. A 
series of reporter cell-to-tumor-cell-ratios, as well as varying total cell numbers were 
evaluated. However, the signals derived from the tumor cell lines, or from 
macrophage cell line coculture were not able to induce the Wnt or HH reporter 
systems in the engineered iMSCs. By contrast, control Hek293 stably transfected 
with the aforementioned reporters were strongly induced by the coculture systems 
suggesting that the MSC may not be as responsive to signaling through the relevant 
receptors (Figure 25-29). 
This was especially true for stimulation of Hek HH reporter cells with HT1080 
(human fibrosarcoma cell line) or MM6 (human macrophage cell line)-derived 
supernatant which led to a roubust induction and to Wnt induction at a much lower 
level. This suggests that soluble factors secreted by HT1080 and MM6 can exert 
their effects through HH signaling which in turn may lead to Wnt signaling potentially 
through pathway cross talk. Alternatively, the supernatant may also contain a small 
amount of Wnt ligands.  
However, the HH or Wnt reporter iMSCs did not show induction upon supernatant 
exposure, however, for the Wnt-responsive cells a positive control using human 
recombinant Wnt3a did lead to increased Gaussia Luciferase signal. There are 
various possible explanations for this observation, including differences between 
Hek293 and iMSC in cell characteristics such as their receptor profile and density, 
or even transfection efficiency. The response of the Hek Wnt reporter cells to Wnt3a 
stimulation yielded higher fold changes to unstimulated control than was seen in the 
iMSCs exposed to the same concentration of Wnt3a. 
Concentrated MM6 supernatant (Amicon centrifugal filter 10kDalton, concentrating 
proteins) increased the Hek reporter signal significantly as compared to 
unconcentrated supernatant, or to unstimulated controls.  By contrast, the iMSC 
reporter cells showed rather decreased reporter activity. This suggests differences 
between Hek and iMSC lines in their response to the MM6 supernatant. There are 
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various potential reasons for this effect, including differences in the signaling 
pathways. One possibility is that these pathways may be more active in the “resting” 
iMSC, and further stimulation leads to downregulation of that pathway. The receptor 
profile may also differ such that a given signal triggers different signaling cascades 
in the cell lines leading either to activation or repression of reporter gene 
expression. 
To better define the activation of the Hek reporter cells with MM6 supernatant, 
various substances were tested for their potential to activate Hek HH cell reporter 
activity, or to reverse stimulatory effects of the MM6 coculture or supernatant. 
Human epidermal growth factor (EGF) was found to be able to activate the Hek HH 
reporter, but did not activate iMSC HH. Crosstalk between the HH cascade and 
EGFR signaling has been previously reported (Bigelow, Jen, Delehedde, Chari, & 
McDonnell, 2005; Kasper et al., 2006; Schnidar et al., 2009). 
 
A 3D tumor model, or so-called tumor spheroid, was also tested in this setting. It 
was thought that it may generate a set of signals that are more in tune with the in 
vivo tumor environment. The analysis of tumor spheroids and their interaction with 
MSCs was found to be time-consuming and complex. Therefore, spheroid invasion 
assays were not suitable for the general screening of prestimulation conditions. 
Notwithstanding, testing pathway specific reporters for their activity in different 
regions of the tumor spheroid with its different gradients of chemokines and hypoxia 
would be interesting and therefore, establishing a suitable iMSC cell line was 
aspired.  
Establishment of a Wnt-responsive cell line with fluorescent protein read-out 
Therapeutic approaches utilizing engineered MSCs are dependent on the 
expression of therapeutic transgenes within the tumor milieu. In order to minimize 
potential side effects when the MSC are recruited to normal tissue, the transgene 
expression can be made more specific for the tumor environment thus limiting 
potential damage to the normal tissues.  
To investigate the tumor milieu and its potential effect on MSCs reporter cells, a 
fluorescent protein read-out was established to measure promoter activity of stably 
transfected MSCs while invading a 3D tumor model. A co-worker in our laboratory, 
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Svenja Rühland describes in her Master’s thesis, MSC invasion into tumor 
spheroids using a mathematical approach to analyze the depth of invasion 
(Rühland, 2014). Stably transfected iMSC with the Bar-Tomato reporter were 
subsequently shown to invade a HUH7 spheroid, Tomato signal and CMFDA label 
were detectable (Figure 32). 
The functionality of stably transfected iMSCs with a Wnt responsive element driving 
Tomato expression was verified in fluorescent microscopy and FACS analysis. 
Stimulation for 24h with recombinant human Wnt3a (75 and 400ng/ml) and LiCl 
(25mM) lead to more Tomato positive cells as well as a higher y-mean in FACS 
analysis (Figure 33). Unfortunately, only a small percentage of cells reacted to the 
more physiologic canonical Wnt pathway stimulator Wnt3a. In accordance with the 
Gaussia Luciferase Wnt reporter experiments, neither HUH7 nor HT1080 tumor cell 
supernatant was able to induce reporter activity in iMSC nor primary MSC Wnt-
Tomato reporter cells (Figure 34). 
In conclusion, stimulation of Wnt responsive elements stably transfected in iMSC or 
primary MSC did not lead to induction within experimental  tumor milieus. Therefore, 
the generated cell line was not suitable for establishing this assay, and the results 
suggest that MSC do not respond strongly to HH or Wnt signals within tumors. The 
current standard using the CCL5/RANTES promoter to drive therapeutic transgene 
expression in engineered MSCs (currently in Phase I/II trials) makes use of 
inflammatory signals within the tumor setting to trigger transgene expression. The 
results presented here suggest that Wnt or HH signaling may not be suitable for 
driving tumor-specific transgene expression in engineered MSC. However, the 
preactivation studies, do suggest that stimulation of MSC with canonical Wnt ligands 
(here Wnt3a) may transiently enhance their tropism for tumor-derived signals. 
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Conclusion & outlook 
• Wnt3a prestimulation enhanced primary MSCs’ migratory potential towards 
tumor conditioned medium. 
• No memory effect was observed, MSCs cultured for two to three passages 
after preconditioning did not show enhanced migratory parameters. 
• It was possible to activate Wnt and Hedgehog pathway specific promoters in 
the tumor milieu, stably transfected into Hek293 cells. 
• MSCs and iMSCs stably transfected with Wnt or Hedgehog pathway specific 
promoters did not show enhanced activity in the tumor milieu. 
• When exposed to concentrated supernatant of a macrophage cell line, iMSC 
Wnt or Hedgehog reporter cells showed decreased reporter activity, in 
contrast to the control Hek reporter cells which showed good induction. 
 
The Wnt- and HH-responsive elements used in this thesis do not appear to be 
suitable for the application as enhancer/promoter system for selectively driving 
therapeutic gene expression in MSCs, as no induction in the experimental tumor 
milieu was observed. Further screening of potential enhancers/promoters is 
necessary to identify the most suitable gene promoters for the therapeutic 
application.  
Further experiments are needed to evaluate the potential of Wnt3a prestimulation of 
MSCs not only in vitro, but also in vivo. Being able to influence MSC directed 
migration towards tumor-derived signals helps us to understand MSC biology better 
as well as opens doors for improving their clinical application.  
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Abbreviations and Symbols 
 
7-AAD 7-Aminoactinomycin D  
ANGPT2 Angiopoietin 2 
att Gateway cloning sites 
Bar β-catenin activated reporter, Wnt-responsive element in 
canonical Wnt repoter plasmids 
bp Base pairs 
BSA Bovine serum albumin 
CAF Carcinoma associated fibroblasts  
CCL2 Chemokine (C-C motif) ligand 2 
CCL5/RANTES Chemokine (C-C motif) ligand 5/regulated on activation, normal 
T cell expressed and secreted 
CD Cluster of differentiation 
CDS Coding sequence 
CEA Carcinoembryonic antigen 
CK1-α Casein kinase 1α 
CM Conditioned-medium 
CMFDA 5-Chloromethylfluorescein diacetate 
CXCR4 C-X-C chemokine receptor type 4 
Dhh Desert hedgehog, Hedgehog signaling 
DMEM Dulbecco’s Modified Eagle’s Medium  
DMSO Dimethylsulfoxide 
Dox Doxycycline 
E.coli Escherichia coli 
EMT Epithelial-mesenchymal transition 
FACS Fluorescence-activated cell sorting 
FCS Fetal calf serum  
FMI Forward migration index, a calculated parameter indicating 
directed cell migration 
Fz Frizzled,  G protein-coupled receptor proteins 
GCV Ganciclovir 
GDEPT Gene-directed enzyme-producing therapy  
Gli Glioma-associated oncogen, Hedgehog signaling 
GSK-3β Glycogen synthase kinase  
hbMSC Human bone marrow derived mesenchymal stem cell; primary 
cells 
hbMSCApp172_
1 
name of primary mesenchymal stem cells used for experiments 
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Hek293 Human embryonic kidney cell; well characterized cell line to 
conduct proof of principle experiments 
HGF Hepatocyte growth factor  
HH Hedgehog 
HSV-tk Herpes simplex thymidine kinase 
HT1080 Human fibrosarcoma cell line 
HT29 Human colorectal adenocarcinoma cell line  
HUH7 Hepatocellular carcinoma cell line 
Ihh Indian hedgehog, Hedgehog signaling 
IL-8 Interleukin-8 
iMSC Immortalized mesenchymal stem cell line 
ITR Inverted terminal repeats 
LiCl Lithium chloride 
MDC Macrophage-derived chemokine 
MIF Migration inhibitory factor  
MM6 Monocytic tumor cell line  
MMP-2 Matrix metallo- proteinase-2  
MSC Mesenchymal stem cell 
NIS Sodium iodide symporter  
Ori Origen of replication 
PBS Phosphate Buffered Saline 
PCR Polymerase chain reaction 
PEDF Human pigment epithelium-derived factor  
PI Propidium iodide 
PKA Protein kinase A  
Ptch1 Protein patched homolog 1, in mice and humans, Hedgehog 
signaling 
Rantes Regulated on activation, normal T cell expressed and secreted 
RLU Relative luciferase unit 
SB100 Sleeping Beauty 100 Transposase  
SDF-1 Stromal-derived factor  
Shh Sonic hedgehog, Hedgehog signaling 
Smo Smoothened, Hedgehog signaling 
SUFU Suppressor of fused 
SW480 Human colorectal adenocarcinoma cell line 
Tet Tetracycline 
TNFα Tumor necrosis factor α 
VEGF Vascular endothelial growth factor 
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